| Abbott Laboratories S.A. (Pty) Ltd |
OSMOLITE |
EACH 100 ML LIQUID CONTAINS
CARNITINE A 0,008 g
PROTEINS A 3,7 g
TAURINE A 0,008 g
VITAMINS A |
F1013 |
Old Medicine |
1997/03/04 |
Registered
|
info |
| Abbott Laboratories S.A. (Pty) Ltd |
OSMOLITE HN |
EACH 100 ML LIQUID CONTAINS
LEVOCARNITINE A 0,011 g
PROTEINS A 4,4 g
TAURINE A 0,011 g
VITAMINS A |
F1014 |
Old Medicine |
1997/03/04 |
Registered
|
info |
| Abbott Laboratories S.A. (Pty) Ltd |
OSMOLITE HN PLUS |
EACH 100 ML LIQUID CONTAINS
LEVOCARNITINE A 15,0 mg
PROTEINS A 5,6 g
TAURINE A 15,0 mg
VITAMINS A |
F1015 |
Old Medicine |
1997/05/16 |
Registered
|
info |
| Abbott Laboratories S.A. (Pty) Ltd |
OMACOR |
EACH CAPSULE CONTAINS
DHA and EPA 840,0 mg |
A380729 |
A38/7.5/0729 |
2012/07/06 |
Registered
|
info |
| Abbvie (Pty) Ltd |
OXYLIN LIQUIFILM STERILE OPHTHALMIC SOLUTION |
EACH 1 ml SOLUTION CONTAINS
OXYMETAZOLINE HYDROCHLORIDE 0,25 mg |
V0041 |
V/15.4/41 |
1988/09/26 |
Registered
|
info |
| Accord Healthcare (Pty) Ltd |
OSTENA 10 |
EACH TABLET CONTAINBS
ALENDRONATE SODIUM EQUIVALENT TO ALENDRONIC ACID 10,0 mg |
421015 |
42/3.2/1015 |
2010/11/26 |
Registered
|
info |
| Accord Healthcare (Pty) Ltd |
OSTENA 70 |
EACH TABLET CONTAINBS
ALENDRONATE SODIUM EQUIVALENT TO ALENDRONIC ACID 70,0 mg |
421016 |
42/3.2/1016 |
2010/11/26 |
Registered
|
info |
| Accord Healthcare (Pty) Ltd |
OPLAXIN 50 mg |
EACH 1,0 ml SOLUTION CONTAINS
OXALIPLATIN 50,0 mg |
460212 |
46/26/0212 |
2016/09/06 |
#N/A
|
info |
| Accord Healthcare (Pty) Ltd |
OPLAXIN 100 mg |
EACH 1,0 ml SOLUTION CONTAINS
OXALIPLATIN 100,0 mg |
460213 |
46/26/0213 |
2016/09/06 |
#N/A
|
info |
| Accord Healthcare (Pty) Ltd |
OREXITAS 2,5 mg |
None |
490038 |
49/2.6.5/0038 |
2021/06/15 |
Registered
|
info |
| Accord Healthcare (Pty) Ltd |
OREXITAS 5 mg |
None |
490039 |
49/2.6.5/0039 |
2021/06/15 |
Registered
|
info |
| Accord Healthcare (Pty) Ltd |
OREXITAS 10 mg |
None |
490040 |
49/2.6.5/0040 |
2021/06/15 |
Registered
|
info |
| Activo Health (Pty) Ltd |
OCUVIG |
None |
490436 |
49/15.1/0436 |
2021/08/17 |
Registered
|
info |
| Actor Pharma (Pty) Ltd - Applicant |
ORALACT MOUTHWASH |
None |
480130 |
48/16.5/0130 |
2022/05/18 |
Registered
|
info |
| Actor Pharma (Pty) Ltd - Applicant |
ORALACT THROAT SPRAY |
None |
480299 |
48/16.5/0299 |
2022/05/18 |
Registered
|
info |
| ADCO DRUG CO (PTY) LTD |
OWBRIDGES LUNG TONIC |
10 ML
ALCOHOL, 95% A 0,135 ML
ANISE OIL A 0,0051 ML
CAPSICUM TINCTURE A 0,0294 ML
CETYLPYRIDINIUM CHLORIDE A 2,5 MG
CHLOROFORM A 0,0877 ML
CLOVE OIL A 0,0051 ML
SOLVENT ETHER A 0,0615 ML |
G0692 |
Old Medicine |
1974/08/10 |
Registered
|
info |
| Adcock Ingram Limited |
OBEX LA |
TABLET
PHENDIMETRAZINE TARTRATE A 105 MG |
C0714 |
Old Medicine |
1970/07/27 |
Registered
|
info |
| Adcock Ingram Limited |
OCULOSAN |
EACH 1 ml CONTAINS
BORIC ACID A 0,2 mg
NAPHAZOLINE NITRATE A 0,05 mg |
H1272 |
Old Medicine |
1975/02/24 |
Registered
|
info |
| Adcock Ingram Limited |
OSELTAMIVIR ADCO 30 mg |
EACH CAPSULE CONTAINS
OSELTAMIVIR PHOSPHATE 30,0 mg |
540687 |
54/20.2.8/0687 |
2020/03/11 |
Registered
|
info |
| Adcock Ingram Limited |
OSELTAMIVIR ADCO 45 mg |
EACH CAPSULE CONTAINS
OSELTAMIVIR PHOSPHATE 45,0 mg |
540688 |
54/20.2.8/0688 |
2020/03/11 |
Registered
|
info |
| Adcock Ingram Limited |
OSELTAMIVIR ADCO 75 mg |
EACH CAPSULE CONTAINS
OSELTAMIVIR PHOSPHATE 75,0 mg |
540689 |
54/20.2.8/0689 |
2020/03/11 |
Registered
|
info |
| Adcock Ingram Critical Care (Pty) Ltd |
ONE -ALPHA DROPS 2 ╡g/ml |
None |
500984 |
50/22.1.4/0984 |
2021/03/16 |
Registered
|
info |
| Adcock Ingram Critical Care (Pty) Ltd |
ONE - ALPHA CAPSULES 1ug |
EACH CAPSULE CONTAINS
ALPHACALCIDOL 1 ug |
M0261 |
M/22.1.4/0261 |
1981/06/15 |
Registered
|
info |
| Adcock Ingram Critical Care (Pty) Ltd |
ONE - ALPHA CAPSULES 0,25 ug |
EACH CAPSULE CONTAINS
ALPHACALCIDOL 0,25 ug |
M0262 |
M/22.1.4/0262 |
1981/06/15 |
Registered
|
info |
| AKROMED PRODUCTS (PTY) LTD |
OVRAL 28 |
None |
H1644 |
Old Medicine |
1975/01/24 |
Registered
|
info |
| ALCON LABORATORIES (SA) (PTY) LTD |
OPTI- FREE EXPRESS MPDS |
EACH 1,0 ml SOLUTION CONTAINS
BORIC ACID E 6,0 mg
DISODIUM EDETATE DIHYDRATE E 0,5 mg
SODIUM CHLORIDE E 1,0 mg |
340432 |
34/34/0432 |
2001/11/10 |
Registered
|
info |
| ALKEM LABORATORIES (PTY) LTD |
OLANZAPINE ALKEM 5 mg |
None |
491013 |
49/2.6.5/1013 |
2021/06/22 |
Registered
|
info |
| ALKEM LABORATORIES (PTY) LTD |
OLANZAPINE ALKEM 10 mg |
None |
491014 |
49/2.6.5/1014 |
2021/06/22 |
Registered
|
info |
| Allergan Pharmaceuticals (Pty) Ltd |
OZURDEX |
EACH INTRAVITREAL IMPLANT CONTAINS
DEXAMETHASONE 700,0 ug |
440045 |
44/15.2/0045 |
2012/07/12 |
#N/A
|
info |
| Alliance Pharma (Pty) Ltd |
ORAJEL MOUTH GEL |
EACH 1 g GEL CONTAINS
BENZOCAINE 100 mg |
280163 |
28/4/0163 |
1994/06/29 |
Registered
|
info |
| Alliance Pharma (Pty) Ltd |
OFTAN TIMOLOL 0,25 % |
EACH 1 ml SOLUTION CONTAINS
TIMOLOL MALEATE EQUIVALENT TO 2,5 mg TIMOLOL |
310278 |
31/15.4/0278 |
1998/08/12 |
#N/A
|
info |
| Alliance Pharma (Pty) Ltd |
OFTAN TIMOLOL 0,5 % |
EACH 1 ml SOLUTION CONTAINS
TIMOLOL MALEATE EQUIVALENT TO 5 mg TIMOLOL |
310279 |
31/15.4/0279 |
1998/08/12 |
#N/A
|
info |
| Alliance Pharma (Pty) Ltd |
OFTAN TIMOLOL 0,25% SDU |
EACH 1,0 ml SOLUTION CONTAINS
TIMOLOL MALEATE EQUIVALENT TO 2,5 mg TIMOLOL |
310276 |
31/15.4/0276 |
1999/05/07 |
#N/A
|
info |
| Alliance Pharma (Pty) Ltd |
OFTAN TIMOLOL 0,5 % SDU |
EACH 1 ml SOLUTION CONTAINS
TIMOLOL MALEATE EQUIVALENT TO 5 mg TIMOLOL |
310277 |
31/15.4/0277 |
1999/05/07 |
#N/A
|
info |
| ALLIED DRUG COMPANY (PTY) LTD |
OLIVE OIL |
EACH 100 ml CONTAINS
OLIVE OIL A 100 ml |
BV0354 |
Old Medicine |
1987/02/03 |
Registered
|
info |
| ALLIED DRUG COMPANY (PTY) LTD |
OLIVE OIL |
EACH 100 ml CONTAINS
LIQUID PARAFFIN A 100 ml |
BV0409 |
Old Medicine |
1987/09/03 |
Registered
|
info |
| Amgen South Africa (Pty)Ltd |
OTEZLA 10 mg |
EACH TABLET CONTAINS
APREMILAST 10,0 mg |
510864 |
51/32/0864 |
2019/06/26 |
Registered
|
info |
| Amgen South Africa (Pty)Ltd |
OTEZLA 20 mg |
EACH TABLET CONTAINS
APREMILAST 20,0 mg |
510865 |
51/32/0865 |
2019/06/26 |
Registered
|
info |
| Amgen South Africa (Pty)Ltd |
OTEZLA 30 mg |
EACH TABLET CONTAINS
APREMILAST 30,0 mg |
510866 |
51/32/0866 |
2019/06/26 |
Registered
|
info |
| ANIPHARM (PTY) LTD |
OVAKRON 40 mg |
EACH TAMPON CONTAINS FLUGESTONE ACETATE 40,0 mg |
88/6 |
88/20.4/0006 |
1989/08/14 |
Registered
|
info |
| ANIPHARM (PTY) LTD |
OVASTIM |
EACH VIAL CONTAINS
SERUM GONADOTROPHIN 6 000,0 iu |
92/1 |
92/20.4/1 |
1993/03/08 |
Registered
|
info |
| ANIPHARM (PTY) LTD |
OVAGEN |
EACH 20 ml SOLUTION CONTAINS
FOLLOTROPIN OVINE PITUATARY 17,6 mg |
95/1 |
95/22.7/1 |
1996/02/09 |
Registered
|
info |
| ASCENDIS ANIMAL HEALTH (PTY) LTD |
OMEPRACOTE |
EACH SYRINGE CONTAINS
OMEPRAZOLE 2,28 g |
2-Jun |
06/8.4.3/02 |
2009/09/10 |
#N/A
|
info |
| Ascendis Pharma (Pty) Ltd |
OROCAINE THROAT LOZENGES |
EACH LOZENGE CONTAINS
BENZOCAINE A 10,8 mg
CETRIMIDE A 0,5 mg |
H1509 |
Old Medicine |
2000/05/24 |
Registered
|
info |
| AstraZeneca Pharmaceuticals (Pty) Ltd- Bryanston |
ONGLYZA 2,5 |
EAVH TABLET CONTAINS
SAXAGLIPTIN 2,5 mg |
430608 |
43/21.2/0608 |
2011/11/25 |
#N/A
|
info |
| AstraZeneca Pharmaceuticals (Pty) Ltd- Bryanston |
ONGLYZA 5 |
EAVH TABLET CONTAINS
SAXAGLIPTIN 5,0 mg |
430609 |
43/21.2/0609 |
2011/11/25 |
#N/A
|
info |
| Aurobindo Pharma (Pty) Ltd |
OLEGRA |
EACH TABLET CONTAINS
DOLUTEGRAVIR SODIUM EQUIVALENT TO DOLUTEGRAVIR 50,0 mg |
510914.913 |
51/20.2.8/0914.913 |
2018/10/26 |
Registered
|
info |
| Aurogen South Africa (Pty) Ltd |
ODRON 35 mg TABLETS |
EACH TABLET CONTAINS
RISEDRONATE 35,0 mg |
450869 |
45/3.2/0869 |
2016/07/29 |
Registered
|
info |
| Aurogen South Africa (Pty) Ltd |
OSSADURA 10 mg |
EACH TABLET CONTAINS
ALENDRONATE SODIUM EQUIVALENT TO ALENDRONIC ACID 10,0 mg |
450582 |
45/3.2/0582 |
2014/06/03 |
#N/A
|
info |
| Aurogen South Africa (Pty) Ltd |
OSSADURA 70 mg |
EACH TABLET CONTAINS
ALENDRONATE SODIUM EQUIVALENT TO ALENDRONIC ACID 70,0 mg |
450583 |
45/3.2/0583 |
2014/06/03 |
#N/A
|
info |
| Aurogen South Africa (Pty) Ltd |
ONZIR 5 |
None |
470599 |
47/2.6.5/0599 |
2021/05/18 |
Registered
|
info |
| Aurogen South Africa (Pty) Ltd |
ONZIR 10 |
None |
470600 |
47/2.6.5/0600 |
2021/05/18 |
Registered
|
info |
| B Braun Medical (Pty) Ltd |
ONDANSETRON B BRAUN 4 mg INJECTION |
EACH 2,0 ml VIAL CONTAINS
ONDANSETRON 4,0 mg |
430892 |
43/5.10/0892 |
2015/11/06 |
#N/A
|
info |
| B Braun Medical (Pty) Ltd |
ONDANSETRON B BRAUN 8 mg INJECTION |
EACH 4,0 ml VIAL CONTAINS
ONDANSETRON 8,0 mg |
430893 |
43/5.10/0893 |
2015/11/06 |
#N/A
|
info |
| BARRS PHARMACEUTICAL INDUSTRIES (PTY) LTD |
OLIVE OIL ALCHEMIST |
Referred to
OLIVE OIL A 100 % |
BV0704 |
Old Medicine |
1987/12/03 |
Registered
|
info |
| BARRS PHARMACEUTICAL INDUSTRIES (PTY) LTD |
OLIVE OIL-DAROL |
EACH 100,0 ml OIL CONTAINS
OLIVE OIL 100,0 ml |
330155 |
33/34/0155 |
2002/03/20 |
#N/A
|
info |
| BAYER (PTY) LTD (ANIMAL HEALTH DIVISION) |
OSPOLOT |
TABLET
SULTHIAME A 50 MG |
B0868 |
Old Medicine |
1969/04/12 |
Registered
|
info |
| BAYER (PTY) LTD (ANIMAL HEALTH DIVISION) |
OSPOLOT |
TABLET
SULTHIAME A 200 MG |
B0873 |
Old Medicine |
1969/04/12 |
Registered
|
info |
| BAYER (PTY) LTD (ANIMAL HEALTH DIVISION) |
ORIDERMYL |
EACH 10 g CONTAINS
LIDOCAINE A 200,0 mg
LINDANE A 50,0 mg
NEOMYCIN SULPHATE A 45,161 mg
NYSTATIN A 208,03 mg
TRIAMCINOLONE ACETONIDE A 10,0 mg |
83/795 |
Old Medicine |
1984/04/18 |
Registered
|
info |
| Biotech Laboratories (Pty) Ltd |
ONDANSETRON 4 mg BIOTECH |
EACH TABLET CONTAINS
ONDANSETRON HYDROCHLORIDE EQUIVALENT TO ONDANSETRON 4,0 mg |
380160 |
38/5.10/0160 |
2006/02/17 |
#N/A
|
info |
| Biotech Laboratories (Pty) Ltd |
ONDANSETRON 8 BIOTECH |
EACH TABLET CONTAINS
ONDANSETRON HYDROCHLORIDE EQUIVALENT TO ONDANSETRON 8,0 mg |
380161 |
38/5.10/0161 |
2006/02/17 |
#N/A
|
info |
| Biotech Laboratories (Pty) Ltd |
ONDANSETRON HEXAL 4 mg BIOTECH |
EACH 2,0 ml AMPOULE CONTAINS
ONDANSETRON HYDROCHLORIDE EQUIVALENT TO ONDANSETRON 4,0 mg |
380200 |
38/5.10/0200 |
2006/07/04 |
#N/A
|
info |
| Biotech Laboratories (Pty) Ltd |
ONDANSETRON 8 mg BIOTECH |
EACH 4,0 ml AMPOULE CONTAINS
ONDANSETRON HYDROCHLORIDE EQUIVALENT TO ONDANSETRON 8,0 mg |
380217 |
38/5.10/0217 |
2006/07/04 |
#N/A
|
info |
| BODENE (PTY) LTD TRADING AS INTRAMED |
OMNOPON-FRESENIUS 10 |
EACH 1 ml AMPOULE CONTAINS
CODEINE HYDROCHLORIDE 0,52 mg
MORPHINE HYDROCHLORIDE 6,72 mg
PAPAVERINE HYDROCHLORIDE 0,6 ml |
K0304 |
K/2.9/304 |
1978/05/15 |
Registered
|
info |
| Austell Pharmaceuticals (Pty) Ltd |
OFLOXACIN 200 mg AUSTELL |
EACH TABLET CONTAINS
OFLOXACINE 200,0 mg |
A390149 |
A39/20.1.1/0149 |
2006/07/07 |
Registered
|
info |
| Austell Pharmaceuticals (Pty) Ltd |
OFLOXACIN 400 mg AUSTELL |
EACH TABLET CONTAINS
OFLOXACINE 400,0 mg |
A390150 |
A39/20.1.1/0150 |
2006/07/07 |
Registered
|
info |
| Camox Pharmaceuticals (Pty) Ltd |
OXYCORREL 5 mg |
EACH CAPSULE CONTAINS :
OXYCODONE HYDROCHLORIDE 5,0 mg |
491082 |
49/2.9/1082 |
2017/12/12 |
#N/A
|
info |
| Camox Pharmaceuticals (Pty) Ltd |
OXYCORREL 10 mg |
EACH CAPSULE CONTAINS :
OXYCODONE HYDROCHLORIDE 10,0 mg |
491083 |
49/2.9/1083 |
2017/12/12 |
#N/A
|
info |
| Camox Pharmaceuticals (Pty) Ltd |
OXYCORREL 20 mg |
EACH CAPSULE CONTAINS :
OXYCODONE HYDROCHLORIDE 20,0 mg |
491084 |
49/2.9/1084 |
2017/12/12 |
#N/A
|
info |
| Cipla Medpro (Pty) Ltd |
ODIMUNE |
EACH TABLET CONTAINS
EFAVIRENZ 600,0 mg
EMTRICITABINE 200,0 mg
TENOFOVIR DISOPROXIL FUMARATE 300,0 mg |
440779 |
44/20.2.8/0779 |
2012/09/02 |
#N/A
|
info |
| Cipla Medpro (Pty) Ltd |
ONBORT |
None |
510053 |
51/26/0053 |
2020/02/04 |
Registered
|
info |
| Cipla Medpro (Pty) Ltd |
OXYMETAZOLINE CIPLA 0,025 |
EACH 1,0 ml SOLUTION CONTAINS
OXYMETAZOLINE HYDROCHLORIDE 0,25 mg |
470790 |
47/16.1/0790 |
2019/03/29 |
Registered
|
info |
| Cipla Medpro (Pty) Ltd |
OXYMETAZOLINE CIPLA 0,05 |
EACH 1,0 ml SOLUTION CONTAINS
OXYMETAZOLINE HYDROCHLORIDE 0,5 mg |
470791 |
47/16.1/0791 |
2019/03/29 |
Registered
|
info |
| Cipla Medpro (Pty) Ltd |
OXYMIST 0,025 |
EACH 1,0 ml SOLUTION CONTAINS
OXYMETAZOLINE HYDROCHLORIDE 0,25 mg |
470792 |
47/16.1/0792 |
2019/03/29 |
Registered
|
info |
| Cipla Medpro (Pty) Ltd |
OXYMIST 0,05 |
EACH 1,0 ml SOLUTION CONTAINS
OXYMETAZOLINE HYDROCHLORIDE 0,5 mg |
470793 |
47/16.1/0793 |
2019/03/29 |
Registered
|
info |
| Cipla Medpro (Pty) Ltd |
OXYSPAS |
EACH TABLET CONTAINS
OXYBUTYNIN CHLORIDE 5,0 mg |
350111 |
35/5.4/0111 |
2002/05/21 |
#N/A
|
info |
| Cipla Medpro (Pty) Ltd |
OCTIN |
EACH 5,0 ml SOLUTION CONTAINS
OFLOXACINE 15,0 mg |
360002 |
36/15.1/0002 |
2003/01/24 |
Registered
|
info |
| Cipla Medpro (Pty) Ltd |
OLEXAR 2,5 |
EACH TABLET CONTAINS
OLANZAPINE 2,5 mg |
370316 |
37/2.6.5/0316 |
2004/12/11 |
#N/A
|
info |
| Cipla Medpro (Pty) Ltd |
OLEXAR-5 |
EACH TABLET CONTAINS
OLANZAPINE 5,0 mg |
370317 |
37/2.6.5/0317 |
2004/12/11 |
#N/A
|
info |
| Cipla Medpro (Pty) Ltd |
OLEXAR-10 |
EACH TABLET CONTAINS
OLANZAPINE 10,0 mg |
370318 |
37/2.6.5/0318 |
2004/12/11 |
#N/A
|
info |
| Cipla Medpro (Pty) Ltd |
ONDANSETRON CIPLA TABLETS 4 |
EACH TABLET CONTAINS
ONDANSETRON HYDROCHLORIDE EQUIVALENT TO ONDANSETRON 4,0 mg |
A380435 |
A38/5.10/0435 |
2005/03/06 |
Registered
|
info |
| Cipla Medpro (Pty) Ltd |
ONDANSETRON CIPLA TABLETS 8 |
EACH TABLET CONTAINS
ONDANSETRON HYDROCHLORIDE EQUIVALENT TO ONDANSETRON 8,0 mg |
A380436 |
A38/5.10/0436 |
2005/03/06 |
Registered
|
info |
| Cipla Medpro (Pty) Ltd |
OSTEOBON 70 |
EACH TABLET CONTAINS
ALENDRONATE SODIUM EQUIVALENT TO ALENDRONIC ACID 70,0 mg |
A390396 |
A39/3.2/0396 |
2005/07/29 |
Registered
|
info |
| Cipla Medpro (Pty) Ltd |
ONCOGEM 200 |
EACH 10,0 ml VIAL CONTAINS
GEMCITABINE HYDROCHLORIDE EQUIVALENT TO GEMCITABINE 200,0 mg |
431171 |
43/26/1171 |
2012/09/14 |
#N/A
|
info |
| Cipla Medpro (Pty) Ltd |
ONCOGEM 1000 |
EACH 50,0 ml VIAL CONTAINS
GEMCITABINE HYDROCHLORIDE EQUIVALENT TO GEMCITABINE 1 000,0 mg |
431172 |
43/26/1172 |
2012/09/14 |
#N/A
|
info |
| Cipla Medpro (Pty) Ltd |
OCUSOPT |
Referred to
TRAVOPROST A |
480400 |
48/15.4/0400 |
2017/02/06 |
Registered
|
info |
| Cipla Medpro (Pty) Ltd |
OXALIPLATIN MEDPRO 50 |
EACH VIAL CONTAINS
OXALIPLATIN 50,0 mg |
460477 |
46/26/0477 |
2017/07/27 |
Registered
|
info |
| Cipla Medpro (Pty) Ltd |
OXALIPLATIN MEDPRO 100 |
EACH VIAL CONTAINS
OXALIPLATIN 100,0 mg |
460478 |
46/26/0478 |
2017/07/27 |
Registered
|
info |
| Cipla Medpro (Pty) Ltd |
OXALIPLATIN 50 CIPLA |
EACH VIAL CONTAINS
OXALIPLATIN 50,0 mg |
471106 |
47/26/1106 |
2017/11/23 |
Registered
|
info |
| Cipla Medpro (Pty) Ltd |
OXALIPLATIN 100 CIPLA |
EACH VIAL CONTAINS
OXALIPLATIN 100,0 mg |
471107 |
47/26/1107 |
2017/11/23 |
Registered
|
info |
| Cipla Medpro (Pty) Ltd |
OTILAN |
EACH 1,0 ml DROPS CONTAINS
MICONAZOLE 23,0 mg
POLYMYXIN B 5500,0 iu
PREDNISOLONE ACETATE 5,0 mg |
31-Jul |
07/17.3/31 |
2011/04/15 |
#N/A
|
info |
| DONMED PHARMACEUTICALS (PTY) LTD |
ORABOLIN |
EACH TABLET CONTAINS
ETHYLESTRENOL A 2,0 MG |
G3193 |
Old Medicine |
1975/12/02 |
Registered
|
info |
| Dr ReddyÆs Laboratories (Pty) Ltd |
OMEZ OTC 10 |
EACH CAPSULE CONTAINS
OMEPRAZOLE 10,0 mg |
340296 |
34/11.4.3/0296 |
2001/06/15 |
#N/A
|
info |
| Dr ReddyÆs Laboratories (Pty) Ltd |
OMEZ OTC 20 |
EACH CAPSULE CONTAINS
OMEPRAZOLE 20,0 mg |
340297 |
34/11.4.3/0297 |
2001/06/15 |
#N/A
|
info |
| Dr ReddyÆs Laboratories (Pty) Ltd |
OMEZ 10 |
EACH CAPSULE CONTAINS
OMEPRAZOLE 10,0 mg |
340299 |
34/11.4.3/0299 |
2001/06/15 |
#N/A
|
info |
| Dr ReddyÆs Laboratories (Pty) Ltd |
OMEZ 20 |
EACH CAPSULE CONTAINS
OMEPRAZOLE 20,0 mg |
340300 |
34/11.4.3/0300 |
2001/06/15 |
#N/A
|
info |
| Dr ReddyÆs Laboratories (Pty) Ltd |
OMEZ 40 |
EACH CAPSULE CONTAINS
OMEPRAZOLE 40,0 mg |
340301 |
34/11.4.3/0301 |
2001/06/15 |
#N/A
|
info |
| Dr ReddyÆs Laboratories (Pty) Ltd |
OSETRON ODT-4 |
EACH TABLET CONTAINS
ONDANSETRON 4,0 mg |
410185 |
41/5.10/0185 |
2007/10/08 |
#N/A
|
info |
| Dr ReddyÆs Laboratories (Pty) Ltd |
OSETRON ODT-8 |
EACH TABLET CONTAINS
ONDANSETRON 8,0 mg |
410186 |
41/5.10/0186 |
2007/10/08 |
#N/A
|
info |
| Elanco Animal Health (Pty) Ltd |
ONSIOR 5 mg TABLETS FOR DOGS |
EACH TABLET CONTAINS
ROBENACOXIB 5,0 mg |
18-Jul |
07/3.1.1/18 |
2011/11/25 |
#N/A
|
info |
| Elanco Animal Health (Pty) Ltd |
ONSIOR 10 mg TABLETS FOR DOGS |
EACH TABLET CONTAINS
ROBENACOXIB A 10,0 mg |
19-Jul |
07/3.1.1/19 |
2011/11/25 |
Registered
|
info |
| Elanco Animal Health (Pty) Ltd |
ONSIOR 20 mg TABLETS FOR DOGS |
EACH TABLET CONTAINS
ROBENACOXIB 20,0 mg |
20-Jul |
07/3.1.1/20 |
2011/11/25 |
#N/A
|
info |
| Elanco Animal Health (Pty) Ltd |
ONSIOR 40 mg TABLETS FOR DOGS |
EACH TABLET CONTAINS
ROBENACOXIB 20,0 mg |
21-Jul |
07/3.1.1/21 |
2011/11/25 |
#N/A
|
info |
| Elanco Animal Health (Pty) Ltd |
ONSIOR 6 mg TABLETS FOR CATS |
EACH TABLET CONTAINS
ROBENACOXIB 6,0 mg |
22-Jul |
07/3.1.1/22 |
2011/11/25 |
#N/A
|
info |
| Elanco Animal Health (Pty) Ltd |
ONSIOR INJECTION |
EACH 1,0 ml SOLUTION CONTAINS
ROBENACOXIB 20,0 mg |
23-Jul |
07/3.1.2.2/23 |
2012/07/27 |
#N/A
|
info |
| Eli Lilly (S.A.) (Pty) Ltd |
OLUMIANT 2 mg |
None |
520229 |
52/3,1/0229 |
2021/01/26 |
Registered
|
info |
| Eli Lilly (S.A.) (Pty) Ltd |
OLUMIANT 4 mg |
None |
520230 |
52/3.1/0230 |
2021/01/26 |
Registered
|
info |
| Equity Pharmaceutical (Pty) Ltd |
ORENCIA 250 mg |
EACH VIAL CONTAINS
ABATACEPT 250,0 mg |
411061 |
41/3.1/1061 |
2009/04/12 |
#N/A
|
info |
| Equity Pharmaceutical (Pty) Ltd |
ORENCIA 125 mg |
EACH PRE-FILLED SYRINGE CONTAINS
ABATACEPT 125,0 mg |
470467 |
47/3.1/0467 |
2016/04/21 |
Registered
|
info |
| Eurolab (Pty) Ltd |
OXILICO 50 |
None |
511096 |
51/26/1096 |
2020/07/28 |
Registered
|
info |
| Eurolab (Pty) Ltd |
OXILICO 100 |
None |
511097 |
51/26/1097 |
2020/07/28 |
Registered
|
info |
| Eurolab (Pty) Ltd |
OXILICO 200 |
None |
511098 |
51/26/1098 |
2020/07/28 |
Registered
|
info |
| Forrester Pharma (Pty) Ltd |
OROZYP ODT 5 |
None |
500304 |
50/2.6.5/0304 |
2021/02/02 |
Registered
|
info |
| Forrester Pharma (Pty) Ltd |
OROZYP ODT 10 |
None |
500305 |
50/2.6.5/0305 |
2021/02/02 |
Registered
|
info |
| Forrester Pharma (Pty) Ltd |
OROZYP ODT 15 |
None |
500306 |
50/2.6.5/0306 |
2021/02/02 |
Registered
|
info |
| Forrester Pharma (Pty) Ltd |
OROZYP ODT 20 |
None |
500307 |
50/2.6.5/0307 |
2021/02/02 |
Registered
|
info |
| Fresenius Medical Care South Africa (Pty) Ltd |
OMNOPON-FRESENIUS 20 |
EACH 1 ml CONTAINS
CODEINE HYDROCHLORIDE A 1,04 mg
MORPHINE HYDROCHLORIDE A 13,44 mg
PAPAVERINE HYDROCHLORIDE A 1,2 mg |
B1006 |
Old Medicine |
1969/05/12 |
Registered
|
info |
| Fresenius Kabi Manufacturing SA (Pty) Ltd û Korsten- PE |
OXALIPLATIN 50 mg/10 ml FRESENIUS |
None |
460897 |
46/26/0897 |
2021/04/05 |
Registered
|
info |
| Fresenius Kabi Manufacturing SA (Pty) Ltd û Korsten- PE |
OXALIPLATIN 100 mg/20 ml FRESENIUS |
None |
460898 |
46/26/0898 |
2021/04/05 |
Registered
|
info |
| Fresenius Kabi Manufacturing SA (Pty) Ltd û Korsten- PE |
ONDANSETRON 4 mg/2 ml FRESENIUS |
EACH 1,0 ml SOLUTION CONTAINS
ONDANSETRON HYDROCHLORIDE DIHYDRATE EQUIVALENT TO ONDANSETRON 2,0 mg |
430542 |
43/5.10/0542 |
2012/07/27 |
Registered
|
info |
| Fresenius Kabi Manufacturing SA (Pty) Ltd û Korsten- PE |
ONDANSETRON 8 mg/4 ml FRESENIUS |
EACH 1,0 ml SOLUTION CONTAINS
ONDANSETRON HYDROCHLORIDE DIHYDRATE EQUIVALENT TO ONDANSETRON 2,0 mg |
430543 |
43/5.10/0543 |
2012/07/27 |
Registered
|
info |
| Fresenius Kabi South Africa (Pty) Limited (TPN Site) |
OSVAREN |
EACH TABLET CONTAINS
CALCIUM ACETATE 435,0 mg
MAGNESIUM CARBONATE 235,0 mg |
450919 |
45/24/0919 |
2017/11/23 |
#N/A
|
info |
| GAREC (PTY) LTD |
OTOCLOR 250 |
EACH CAPSULE CONTAINS
CEFACLOR 250,0 mg |
310104 |
31/20.1.1/0104 |
1997/10/14 |
#N/A
|
info |
| GAREC (PTY) LTD |
OTOCLOR 500 |
EACH CAPSULE CONTAINS
CEFACLOR 500,0 mg |
310105 |
31/20.1.1/0105 |
1997/10/14 |
#N/A
|
info |
| GE Healthcare (Pty) Ltd |
OMNIPAQUE INJECTION 300 mg I/ml (20 ml) |
EACH 1 ml CONTAINS
IOHEXOL (ANHYDROUS) EQUIVALENT TO 300 mg IODINE |
R0131 |
R/28/131 |
1984/12/04 |
#N/A
|
info |
| GE Healthcare (Pty) Ltd |
OMNIPAQUE INJECTION 300 mg I/ml (50 ml) |
EACH 1 ml SOLUTION CONTAINS
IOHEXOL ANHYDROUS, EQUIVALENT TO 300 mg IODINE |
R0132 |
R/28/132 |
1984/12/04 |
#N/A
|
info |
| GE Healthcare (Pty) Ltd |
OMNIPAQUE INJECTION 350 mg I/ml (50 ml) |
EACH 1 ml SOLUTION CONTAINS
IOHEXOL ANHYDROUS, EQUIVALENT TO 350 mg IODINE |
R0134 |
R/28/134 |
1984/12/04 |
#N/A
|
info |
| GE Healthcare (Pty) Ltd |
OMNIPAQUE INJECTION 300 mg I/ml (100 ml) |
EACH 1 ml SOLUTION CONTAINS
IOHEXOL ANHYDROUS, EQUIVALENT TO 300 mg IODINE |
X0080 |
X/28/80 |
1990/09/02 |
Registered
|
info |
| GE Healthcare (Pty) Ltd |
OMNIPAQUE INJECTION 350 mg I/ml (100 ml) |
EACH 1 ml SOLUTION CONTAINS
IOHEXOL ANHYDROUS, EQUIVALENT TO 350 mg IODINE |
X0081 |
X/28/81 |
1990/09/02 |
Registered
|
info |
| GE Healthcare (Pty) Ltd |
OMNISCAN 10 ml |
EACH 1 ml SOLUTION CONTAINS
GADODIAMIDE 287 mg |
290563 |
29/28/0563 |
1995/03/23 |
#N/A
|
info |
| GE Healthcare (Pty) Ltd |
OMNISCAN 15 ml |
EACH 1 ml SOLUTION CONTAINS
GADODIAMIDE 287 mg |
290564 |
29/28/0564 |
1995/03/23 |
#N/A
|
info |
| GE Healthcare (Pty) Ltd |
OMNISCAN 20 ml |
EACH 1 ml SOLUTION CONTAINS
GADODIAMIDE 287 mg |
290565 |
29/28/0565 |
1995/03/23 |
#N/A
|
info |
| GE Healthcare (Pty) Ltd |
OMNISCAN 5 ml |
EACH 5 ml SOLUTION CONTAINS :
GADODIAMIDE 287 mg |
300159 |
30/28/0159 |
1996/08/10 |
#N/A
|
info |
| GE Healthcare (Pty) Ltd |
OMNIPAQUE 300 mg I/ml 200 ml (POLYPROPYLENE BOTTLE) |
EACH 1,0 ml SOLUTION CONTAINS
IOHEXOL EQUIVALENT TO IODINE 300,0 mg |
350381 |
35/28/0381 |
2002/11/15 |
#N/A
|
info |
| GE Healthcare (Pty) Ltd |
OMNIPAQUE 350 mg I/ml 200 ml (POLYPROPYLENE BOTTLE) |
EACH 1,0 ml SOLUTION CONTAINS
IOHEXOL EQUIVALENT TO IODINE 350,0 mg |
350383 |
35/28/0383 |
2002/11/15 |
#N/A
|
info |
| GE Healthcare (Pty) Ltd |
OMNIPAQUE 300 mg I/ml 500 ml (POLYPROPYLENE BOTTLE) |
EACH 1,0 ml SOLUTION CONTAINS
IOHEXOL EQUIVALENT TO IODINE 300,0 g |
350389 |
35/28/0389 |
2002/11/15 |
#N/A
|
info |
| GE Healthcare (Pty) Ltd |
OMNIPAQUE 350 mg I/ml 500 ml (POLYPROPYLENE BOTTLE) |
EACH 1,0 ml SOLUTION CONTAINS
IOHEXOL EQUIVALENT TO IODINE 350,0 mg |
350391 |
35/28/0391 |
2002/11/15 |
#N/A
|
info |
| Gen-Eye (Pty) Ltd |
OPTIPHEN 0,5 % EYE DROPS |
None |
470254 |
47/15.1/0254 |
2021/02/03 |
Registered
|
info |
| GENPHARM PHARMACEUTICALS (1993) (PTY) LTD |
ORAPEN 125 mg TABLETS* |
EACH TABLET CONTAINS
PHENOXYMETHYLPENICILLIN 125,0 mg |
B0050 |
B/20.1.2/50 |
1970/09/01 |
Registered
|
info |
| GENPHARM PHARMACEUTICALS (1993) (PTY) LTD |
ORAPEN 250 mg TABLETS* |
EACH TABLET CONTAINS
FENOKSIMETILPENICILLIN 250,0 mg |
B0051 |
B/20.1.2/51 |
1970/09/01 |
Registered
|
info |
| GENPHARM PHARMACEUTICALS (1993) (PTY) LTD |
OPTACIN OINTMENT |
1 G
NEOMYCIN SULPHATE A 8 MG
PREDNISOLONE A 5 MG |
G1967 |
Old Medicine |
1974/11/26 |
Registered
|
info |
| GENPHARM PHARMACEUTICALS (1993) (PTY) LTD |
OXYTET OINTMENT |
100 G
OXYTETRACYCLINE HYDROCHLORIDE A 3 G |
G2021 |
Old Medicine |
1974/11/27 |
Registered
|
info |
| GENPHARM PHARMACEUTICALS (1993) (PTY) LTD |
OPTACIN EYE OINTMENT/OOGSALF |
EACH GRAM CONTAINS
NEOMYCIN SULPHATE A 8,0 mg
PREDNISOLONE A 5,0 mg |
H1210 |
Old Medicine |
1975/01/21 |
Registered
|
info |
| GENPHARM PHARMACEUTICALS (1993) (PTY) LTD |
OPTACIN EAR DROPS/OORDRUPPELS |
EACH 100 ml CONTAINS
LIDOCAINE HYDROCHLORIDE A 1,0 g
NEOMYCIN SULPHATE A 0,8 g
PREDNISOLONE A 0,5 g |
H1419 |
Old Medicine |
1975/04/02 |
Registered
|
info |
| GlaxoSmithKline Consumer Healthcare SA (Pty) Ltd |
OTRIVIN PLUS |
None |
460819 |
46/16.1/0819 |
2021/02/23 |
Registered
|
info |
| GlaxoSmithKline Consumer Healthcare SA (Pty) Ltd |
OTRIVIN PAED |
EACH 1 ml CONTAINS
XYLOMETAZOLINE HYDROCHLORIDE 0,5 mg |
H1381 |
H/16.1/1381 |
1992/06/24 |
Registered
|
info |
| GlaxoSmithKline Consumer Healthcare SA (Pty) Ltd |
OTRIVIN ADULT |
EACH 1 ml CONTAINS
XYLOMETAZOLINE HYDROCHLORIDE 1,0 mg |
H1382 |
H/16.1/1382 |
1992/06/24 |
Registered
|
info |
| GlaxoSmithKline Consumer Healthcare SA (Pty) Ltd |
OTRIVIN MENTHOL |
EACH 1 ml CONTAINS
XYLOMETAZOLINE HYDROCHLORIDE 1,0 mg |
310319 |
31/16.1/0319 |
1999/01/27 |
Registered
|
info |
| GlaxoSmithKline Consumer Healthcare SA (Pty) Ltd |
OTRISALINE SOLUTION |
EACH 1,0 ml SOLUTION CONTAINS
SODIUM CHLORIDE O 7,40 mg |
340388 |
34/34/0388 |
2003/06/06 |
#N/A
|
info |
| GlaxoSmithKline South Africa (Pty) Limited |
ORNACOL* |
EACH CAPSULE CONTAINS
DEXTROMETHORPHAN HYDROBROMIDE 30 mg
PHENYLPROPANOLAMINE 25 mg |
G0081 |
G/10.1/81 |
1974/08/14 |
Registered
|
info |
| GlaxoSmithKline South Africa (Pty) Limited |
ORNACOL |
EACH 5 ml LIQUID CONTAINS
DEXTROMETHORPHAN HYDROBROMIDE 15 mg
PHENYLPROPANOLAMINE HYDROCHLORIDE 12,5 mg |
G0082 |
G/10.1/82 |
1974/09/25 |
Registered
|
info |
| GlaxoSmithKline South Africa (Pty) Limited |
OILATUM PLUS |
EACH 100,0 g LIQUID CONTAINS
BENZALKONIUM CHLORIDE 6,0 g
LIGHT LIQUID PARAFFIN 52,5 g
TRICLOSAN 2,0 g |
310181 |
31/13.9/0181 |
1998/02/26 |
Registered
|
info |
| GR PHARMACEUTICALS (1967) (PTY) LTD |
OLINO |
5 ML
BENZOIN A 0,113 G
CREOSOTE A 0,060 ML
PREPARED STORAX A 0,007 G |
G0679 |
Old Medicine |
1974/08/10 |
Registered
|
info |
| Guerbet South Africa (Pty) Ltd |
OPTIRAY 320 - 50 ml |
EACH 1 ml SOLUTION CONTAINS
IOVERSOL EQUIVALENT TO 320 mg ORGANICALLY BOUND IODINE |
Z0412 |
Z/28/412 |
1992/09/18 |
Registered
|
info |
| Guerbet South Africa (Pty) Ltd |
OPTIRAY 300 - 30 ml |
EACH 1 ml SOLUTION CONTAINS
IOVERSOL EQUIVALENT TO 300 mg ORGANICALLY BOUND IODINE |
Z0414 |
Z/28/414 |
1992/09/18 |
Registered
|
info |
| Guerbet South Africa (Pty) Ltd |
OPTIRAY 240 - 50 ml |
EACH 1 ml SOLUTION CONTAINS
IOVERSOL EQUIVALENT TO 240 mg ORGANICALLY BOUND IODINE |
Z0416 |
Z/28/416 |
1992/09/18 |
Registered
|
info |
| Guerbet South Africa (Pty) Ltd |
OPTIRAY 300 - 100 ml |
EACH 1 ml SOLUTION CONTAINS
IOVERSOL EQUIVALENT TO 300 mg ORGANICALLY BOUND IODINE |
Z0417 |
Z/28/417 |
1992/09/18 |
Registered
|
info |
| Guerbet South Africa (Pty) Ltd |
OPTIRAY 300 - 50 ml |
EACH 1 ml SOLUTION CONTAINS
IOVERSOL EQUIVALENT TO 300 mg ORGANICALLY BOUND IODINE |
Z0418 |
Z/28/418 |
1992/09/18 |
Registered
|
info |
| Guerbet South Africa (Pty) Ltd |
OPTIRAY 240 - 100 ml |
EACH 1 ml SOLUTION CONTAINS
IOVERSOL EQUIVALENT TO 240 mg ORGANICALLY BOUND IODINE |
Z0419 |
Z/28/419 |
1992/09/18 |
Registered
|
info |
| Guerbet South Africa (Pty) Ltd |
OPTIRAY 350 - 50 ml |
EACH 1 ml SOLUTION CONTAINS
IOVERSOL EQUIVALENT TO 350 mg ORGANICALLY BOUND IODINE |
Z0420 |
Z/28/420 |
1992/09/18 |
Registered
|
info |
| Guerbet South Africa (Pty) Ltd |
OPTIRAY 320 - 100 ml |
EACH 1 ml SOLUTION CONTAINS
IOVERSOL EQUIVALENT TO 320 mg ORGANICALLY BOUND IODINE |
Z0421 |
Z/28/421 |
1992/09/18 |
Registered
|
info |
| Guerbet South Africa (Pty) Ltd |
OPTIRAY 350 - 100 ml |
EACH 1 ml SOLUTION CONTAINS
IOVERSOL EQUIVALENT TO 350 mg ORGANICALLY BOUND IODINE |
Z0422 |
Z/28/422 |
1992/09/18 |
Registered
|
info |
| Guerbet South Africa (Pty) Ltd |
OPTIRAY 300-125 ml |
EACH 125 ml SOLUTION CONTAINS :
IOVERSOL 79,5 g |
300281 |
30/28/0281 |
1996/08/11 |
#N/A
|
info |
| Guerbet South Africa (Pty) Ltd |
OPTIRAY 350-125 ml |
EACH 125 ml SOLUTION CONTAINS :
IOVERSOL 92,63 g |
300282 |
30/28/0282 |
1996/08/11 |
#N/A
|
info |
| Guerbet South Africa (Pty) Ltd |
OPTIRAY 300 - 500 ml |
EACH 1,0 ml SOLUTION CONTAINS
IOVERSOL EQUIVALENT TO IODINE 300,0 mg |
340099 |
34/28/0099 |
2003/11/12 |
#N/A
|
info |
| Guerbet South Africa (Pty) Ltd |
OPTIRAY 320 - 500 ml |
EACH 1,0 ml SOLUTION CONTAINS
IOVERSOL EQUIVALENT TO IODINE 320,0 mg |
340100 |
34/28/0100 |
2003/11/12 |
Registered
|
info |
| Guerbet South Africa (Pty) Ltd |
OPTIRAY 350 |
EACH 1,0 ml SOLUTION CONTAINS
IOVERSOL EQUIVALENT TO IODINE 350,0 mg |
340101 |
34/28/0101 |
2003/11/12 |
#N/A
|
info |
| Guerbet South Africa (Pty) Ltd |
OPTIRAY 300 - 75 ml |
EACH 1,0 ml SOLUTION CONTAINS
IOVERSOL EQUIVALENT TO IODINE 300,0 mg |
A390614 |
A39/28/0614 |
2006/01/12 |
Registered
|
info |
| Guerbet South Africa (Pty) Ltd |
OPTIRAY 320 - 75 ml |
EACH 1,0 ml SOLUTION CONTAINS
IOVERSOL EQUIVALENT TO ORGANICALLY BOUND IODINE 320,0 mg |
A400245 |
A40/28/0245 |
2007/10/08 |
Registered
|
info |
| Guerbet South Africa (Pty) Ltd |
OPTIRAY 350 - 75 ml |
EACH 1,0 ml SOLUTION CONTAINS
IOVERSOL EQUIVALENT TO ORGANICALLY BOUND IODINE 350,0 mg |
A400246 |
A40/28/0246 |
2007/10/08 |
Registered
|
info |
| Gulf Drug Company (Pty) Ltd |
OCIP |
None |
430184 |
43/15.1/0184 |
2021/03/02 |
Registered
|
info |
| Gulf Drug Company (Pty) Ltd |
OCIP |
None |
430184 |
43/15.1/0184 |
2021/02/03 |
Registered
|
info |
| Gulf Drug Company (Pty) Ltd |
OXPOLA 0,25 mg |
EACH TABLET CONTAINS
PRAMIPEXOLE DIHYDROCHLORIDE 0,25 mg |
430133 |
43/5.4.1/0133 |
2012/10/26 |
Registered
|
info |
| Gulf Drug Company (Pty) Ltd |
OXPOLA 0,125 mg |
EACH TABLET CONTAINS
PRAMIPEXOLE DIHYDROCHLORIDE 0,125 mg |
430134 |
43/5.4.1/0134 |
2012/10/26 |
Registered
|
info |
| Gulf Drug Company (Pty) Ltd |
OXPOLA 1,0 mg |
EACH TABLET CONTAINS
PRAMIPEXOLE DIHYDROCHLORIDE 1,0 mg |
430135 |
43/5.4.1/0135 |
2012/10/26 |
Registered
|
info |
| Gulf Drug Company (Pty) Ltd |
OCCUMOL 0,5 % (EYE DROP) |
EACH 1,0 ml DROPS CONTAINS
TIMOLOL MALEATE EQUIVALENT TO TIMOLOL 5,0 mg |
430136 |
43/15.4/0136 |
2013/10/10 |
#N/A
|
info |
| Gulf Drug Company (Pty) Ltd |
OCCUMOL 0,25 % (EYE DROP) |
EACH 1,0 ml DROPS CONTAINS
TIMOLOL MALEATE EQUIVALENT TO TIMOLOL 2,5 mg |
430137 |
43/15.4/0137 |
2013/10/10 |
#N/A
|
info |
| Hetero Drugs South Africa (Pty) Ltd |
OSTEORIX 30 mg |
None |
520428.42 |
52/3.1/0428.420 |
2021/04/13 |
Registered
|
info |
| Hetero Drugs South Africa (Pty) Ltd |
OSTEORIX 60 mg |
EACH TABLET CONTAINS
ETORICOXIB 60,0 mg |
520429.421 |
52/3.1/0429.421 |
2021/04/13 |
Registered
|
info |
| Hetero Drugs South Africa (Pty) Ltd |
OSTEORIX 90 mg |
EACH TABLET CONTAINS
ETORICOXIB 90,0 mg |
520430.422 |
52/3.1/0430.422 |
2021/04/13 |
Registered
|
info |
| Hetero Drugs South Africa (Pty) Ltd |
OSTERORIX 120 mg |
EACH TABLET CONTAINS
ETORICOXIB 120,0 mg |
520431.423 |
52/3.1/0431.423 |
2021/04/13 |
Registered
|
info |
| HEXAL PHARMA (SA) (PTY) LTD |
OCTREOTIDE HEXAL 0,05 mg |
EACH 1,0 ml SOLUTION CONTAINS
OCTREOTIDE 0,05 mg |
A400314 |
A40/34/0314 |
2008/04/18 |
Registered
|
info |
| HEXAL PHARMA (SA) (PTY) LTD |
OCTREOTIDE HEXAL 0,1 mg |
EACH 1,0 ml SOLUTION CONTAINS
OCTREOTIDE 0,1 mg |
A400315 |
A40/34/0315 |
2008/04/18 |
Registered
|
info |
| Ingelheim Pharmaceuticals (Pty) Ltd û Ferndale |
OFEV 100 mg |
None |
520153 |
52/26/0153 |
2020/09/22 |
Registered
|
info |
| Ingelheim Pharmaceuticals (Pty) Ltd û Ferndale |
OFEV 150 mg |
None |
520154 |
52/26/0154 |
2020/09/22 |
Registered
|
info |
| Innovata Pharmaceuticals |
OXY 250 |
EACH CAPSULE CONTAINS
OXYTETRACYCLINE HYDROCHLORIDE 250 mg |
X0077 |
X/20.1.1/77 |
1990/11/16 |
Registered
|
info |
| iNova Pharmaceuticals (Pty) Ltd |
OROFLAM LOZENGES |
EACH LOZENGE CONTAINS
BENZYDAMINE HYDROCHLORIDE 3,0 mg
CETYLPYRIDINIUM CHLORIDE 1,33 mg |
340445 |
34/16.4/0445 |
2001/08/10 |
#N/A
|
info |
| iNova Pharmaceuticals (Pty) Ltd |
ORANIX |
EACH 15,0 ml SOLUTION CONTAINS
BENZYDAMINE HYDROCHLORIDE 22,5 mg
CHLORHEXIDINE GLUCONATE 18,0 mg |
340391 |
34/16.4/0391 |
2001/11/10 |
#N/A
|
info |
| Intervet South Africa (Pty) Ltd |
OVARID 20 mg TABLETS |
EACH TABLET CONTAINS
MEGESTROL ACETATE A 20 mg |
83/589 |
Old Medicine |
1993/11/01 |
Registered
|
info |
| Intervet South Africa (Pty) Ltd |
OVARID 5 mg TABLETS |
EACH TABLET CONTAINS
MEGESTROL ACETATE A 5,0 mg |
83/588 |
Old Medicine |
1993/11/01 |
Registered
|
info |
| Intervet South Africa (Pty) Ltd |
OVALYSE |
EACH 2,0 ml SOLITION CONTAINS FERTIRELIN 100,0 ug |
87/7 |
87/22.7/7 |
1989/06/09 |
Registered
|
info |
| Intervet South Africa (Pty) Ltd |
OPTIMMUNE |
EACH 1,0 g OINTMENT CONTAINS
CICLOSPORIN 2,0 mg |
97/15 |
97/17.4/15 |
2000/02/15 |
Registered
|
info |
| Intervet South Africa (Pty) Ltd |
OTOMAX EAR DROPS |
EACH 1,0 g VISCOUS SUSPENSION CONTAINS
BETAMETHASONE VALERATE EQUIVALENT TO BETAMETHASONE 1,0 mg
CLOTRIMAZOLE 10,0 mg
GENTAMICIN SULPHATE EQUIVALENT TO GENTAMICIN 3,0 mg |
98/11 |
98/15.4.1/11 |
2001/06/04 |
Registered
|
info |
| Intervet South Africa (Pty) Ltd |
ORBAX 6,25 mg TABLETS |
EACH TABLET CONTAINS
ORBIFLOXACIN 6,25 mg |
99/1 |
99/21.1/1 |
2001/04/19 |
Registered
|
info |
| Intervet South Africa (Pty) Ltd |
ORBAX 25 mg TABLETS |
EACH TABLET CONTAINS
ORBIFLOXACIN 25,0 mg |
99/2 |
99/21.1/2 |
2001/04/19 |
Registered
|
info |
| Intervet South Africa (Pty) Ltd |
ORBAX 75 mg TABLETS |
EACH TABLET CONTAINS
ORBIFLOXACIN 75,0 mg |
99/3 |
99/21.1/3 |
2001/04/19 |
Registered
|
info |
| iPharma (Pty) Ltd |
OXYREST |
EACH TABLET CONTAINS
OXYBUTYNIN CHLORIDE 5,0 mg |
370106 |
37/5.4/0106 |
2005/11/25 |
Registered
|
info |
| Janssen Pharmaceutica (Pty) Ltd |
OPSUMIT |
None |
490271 |
49/7.1.3/0271 |
2021/09/21 |
Registered
|
info |
| Johnson & Johnson (Pty) Ltd û East London |
ORALDINE MOUTHWASH |
EACH 100 ml SOLUTION CONTAINS
HEXETIDINE 0,1 g |
C0075 |
C/16.4/75 |
1970/11/18 |
Registered
|
info |
| Johnson & Johnson (Pty) Ltd û East London |
ORALDINE SPRAY |
EACH 100 ml CONTAINS
HEXETIDINE 0,2 g |
E0200 |
E/16.4/200 |
1974/03/11 |
Registered
|
info |
| Johnson & Johnson (Pty) Ltd û East London |
ORALDETTES |
EACH LOZENGE CONTAINS
BENZALKONIUM CHLORIDE SOLUTION 0,001 ml |
J0247 |
J/16.4/247 |
1976/12/22 |
Registered
|
info |
| Johnson & Johnson (Pty) Ltd û East London |
ORALFRICE |
EACH 1 g TOOTHPASTE CONTAINS
HEXETIDINE 1 mg |
P0040 |
P/16.4/40 |
1983/05/16 |
Registered
|
info |
| Key Oncologics (Pty) Ltd |
OXALIPLATIN KEY 50 |
EACH VIAL CONTAINS
OXALIPLATIN 50,0 mg |
450330 |
45/26/0330 |
2015/11/26 |
Registered
|
info |
| Key Oncologics (Pty) Ltd |
OXLIPLATIN KEY 100 |
EACH VIAL CONTAINS
OXALIPLATIN 100,0 mg |
450331 |
45/26/0331 |
2015/11/26 |
Registered
|
info |
| LeBasi Pharmaceuticals (Pty) Ltd |
OBESAN X |
TABLET
PHENDIMETRAZINE TARTRATE A 35 MG |
C0877 |
Old Medicine |
1970/09/15 |
Registered
|
info |
| LeBasi Pharmaceuticals (Pty) Ltd |
OLMETEC PLUS 20/12,5 |
EACH TABLET CONTAINS
HYDROCHLOROTHIAZIDE 12,5 mg
OLMESARTAN MEDOXOMIL 20,0 mg |
410337 |
41/7.1.3/0337 |
2016/02/18 |
#N/A
|
info |
| LeBasi Pharmaceuticals (Pty) Ltd |
OLMETEC PLUS 20/25 |
None |
410338 |
41/7.1.3/338 |
2016/02/18 |
Registered
|
info |
| LeBasi Pharmaceuticals (Pty) Ltd |
OMESAR PLUS 20/12,5 mg |
EACH TABLET CONTAINS
HYDROCHLOROTHIAZIDE 12,5 mg
OLMESARTAN MEDOXOMIL 20,0 mg |
420769 |
42/7.1.3/0769 |
2016/02/18 |
#N/A
|
info |
| LeBasi Pharmaceuticals (Pty) Ltd |
OMESAR PLUS 20/25 mg |
EACH TABLET CONTAINS
HYDROCHLOROTHIAZIDE 25,0 mg
OLMESARTAN MEDOXOMIL 20,0 mg |
420770 |
42/7.1.3/0770 |
2016/02/18 |
#N/A
|
info |
| LeBasi Pharmaceuticals (Pty) Ltd |
OLMETEC 40 |
None |
400405 |
40/7.1.3/0405 |
2022/02/15 |
Registered
|
info |
| LeBasi Pharmaceuticals (Pty) Ltd |
OMESAR 10 |
None |
400406.403 |
40/7.1.3/0406.403 |
2022/02/15 |
Registered
|
info |
| LeBasi Pharmaceuticals (Pty) Ltd |
OMESAR 20 |
None |
400407.404 |
40/7.1.3/0407.404 |
2022/02/15 |
Registered
|
info |
| LeBasi Pharmaceuticals (Pty) Ltd |
OMESAR 40 |
None |
400408.405 |
40/7.1.3/0408.405 |
2022/02/15 |
Registered
|
info |
| LeBasi Pharmaceuticals (Pty) Ltd |
OLZACAD ODT 5 |
None |
490264 |
49/2.6.5/0264 |
2021/01/06 |
Registered
|
info |
| LeBasi Pharmaceuticals (Pty) Ltd |
OLZACAD ODT 10 |
None |
490265 |
49/2.6.5/0265 |
2021/01/06 |
Registered
|
info |
| LeBasi Pharmaceuticals (Pty) Ltd |
OLZACAD ODT 15 |
None |
490266 |
49/2.6.5/0266 |
2021/01/06 |
Registered
|
info |
| LeBasi Pharmaceuticals (Pty) Ltd |
OLZACAD ODT 20 |
None |
490267 |
49/2.6.5/0267 |
2021/01/06 |
Registered
|
info |
| LeBasi Pharmaceuticals (Pty) Ltd |
ORAP 1 mg |
EACH TABLET CONTAINS
PIMOZIDE 1 mg |
B1017 |
B/2.6.5/1017 |
1979/11/06 |
Registered
|
info |
| LeBasi Pharmaceuticals (Pty) Ltd |
ORAP 4 mg |
EACH TABLET CONTAINS
PIMOZIDE 4,0 mg |
K0137 |
K/2.6.5/137 |
1979/11/06 |
Registered
|
info |
| LeBasi Pharmaceuticals (Pty) Ltd |
OLMETEC 10 |
EACH TABLET CONTAINS
OLMESARTAN MEDOXOMIL 10,0 mg |
A400403 |
A40/7.1.3/0403 |
2009/09/10 |
Registered
|
info |
| LeBasi Pharmaceuticals (Pty) Ltd |
OLMETEC 20 |
EACH TABLET CONTAINS
OLMESARTAN MEDOXOMIL 20,0 mg |
A400404 |
A40/7.1.3/0404 |
2009/09/10 |
Registered
|
info |
| LITHA PHARMA (PTY) LTD |
OLINO OINTMENT |
100 G
CAMPHOR A 6,5 G
EUCALYPTUS OIL A 2,0 G
MENTHOL A 2,0 G
PINE OIL A 0,10 G
TURPENTINE OIL A 3,50 G |
G1980 |
Old Medicine |
1974/11/26 |
Registered
|
info |
| LITHA PHARMA (PTY) LTD |
OMNAIR |
EACH PUFF DELIVERS
CICLESONIDE 50,0 ug |
430008 |
43/21.5.1/0008 |
2013/01/03 |
#N/A
|
info |
| LITHA PHARMA (PTY) LTD |
ORIZA 5 |
None |
480284 |
48/2.6.5/0284 |
2021/04/28 |
Registered
|
info |
| LITHA PHARMA (PTY) LTD |
ORIZA 10 |
None |
480285 |
48/2.6.5/0285 |
2021/04/28 |
Registered
|
info |
| LITHA PHARMA (PTY) LTD |
ORIZA 15 |
None |
480286 |
48/2.6.5/0286 |
2021/04/28 |
Registered
|
info |
| LITHA PHARMA (PTY) LTD |
ORIZA 30 |
None |
480287 |
48/2.6.5/0287 |
2021/04/28 |
Registered
|
info |
| LITHA PHARMA (PTY) LTD |
ORPIC 250 mg TABLETS |
EACH TABLET CONTAINS
CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 250,0 mg |
350101 |
35/20.1.1/0101 |
2002/09/20 |
#N/A
|
info |
| LITHA PHARMA (PTY) LTD |
ORPIC 500 mg TABLETS |
EACH TABLET CONTAINS
CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg |
350102 |
35/20.1.1/0102 |
2002/09/20 |
#N/A
|
info |
| LITHA PHARMA (PTY) LTD |
ORPIC 750 mg TABLETS |
EACH TABLET CONTAINS
CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 750,0 mg |
350103 |
35/20.1.1/0103 |
2002/09/20 |
Registered
|
info |
| LITHA PHARMA (PTY) LTD |
ORPIC 2 mg/ml IV |
EACH 1,0 ml SOLUTION CONTAINS
CIPROFLOXACIN LACTATE EQUIVALENT TO CIPROFLOXACIN 2,0 mg |
A400454 |
A40/20.1.1/0454 |
2007/10/08 |
Registered
|
info |
| LITHA PHARMA (PTY) LTD |
OCULET |
EACH 1,0 ml SOLUTION CONTAINS
POVIDONE 25 20,0 mg |
410629 |
41/15.4/0629 |
2009/09/10 |
#N/A
|
info |
| LITHA PHARMA (PTY) LTD |
OSTEONEL ONCE-A-WEEK |
EACH TABLET CONTAINS
RISEDRONATE SODIUM 35,0 mg |
430636 |
43/3.2/0636 |
2013/10/10 |
Registered
|
info |
| LITHA PHARMA (PTY) LTD |
ORATANE 40 mg |
EACH CAPSULE CONTAINS
ISOTRETINOIN 40,0 mg |
420460 |
42/13.4.2/0460 |
2015/01/10 |
#N/A
|
info |
| LITHA PHARMA (PTY) LTD |
OLAZ 5 |
None |
490495 |
49/2.6.5/0495 |
2021/06/22 |
Registered
|
info |
| LITHA PHARMA (PTY) LTD |
OLAZ 10 |
None |
490496 |
49/2.6.5/0496 |
2021/06/22 |
Registered
|
info |
| LITHA PHARMA (PTY) LTD |
OCROTIN 0,05 mg/ML IV |
None |
490287 |
49/34/0287 |
2022/05/31 |
Registered
|
info |
| LITHA PHARMA (PTY) LTD |
OCROTIN 0,10 mg/ML IV |
None |
490288 |
49/34/0288 |
2022/05/31 |
Registered
|
info |
| LONEHILL DISPENSARY AND MEDICINE DEPOT * |
ORAJECT CIRCULON PASTE |
EACH ML CONTAINS
ISOXSUPRINE HYDROCHLORIDE A 40,0 mg |
89/9 |
Old Medicine |
1988/09/14 |
Registered
|
info |
| M I DESATNIK |
OMEGA ALL PAIN POWDERS |
POWDER (732,5 MG)
ASPIRIN A 600 MG
CAFFEINE CITRATE A 125 MG |
B1116 |
Old Medicine |
1969/03/12 |
Registered
|
info |
| M I DESATNIK |
OMEGA COMPLEXION MIXTURE |
5 ML
FERRIC AMMONIUM CITRATE A 52,67 MG
MAGNESIUM SULPHATE A 60 MG |
E1344 |
Old Medicine |
1972/09/08 |
Registered
|
info |
| M I DESATNIK |
OMEGA LAXATIVE MIXTURE |
15 ML
MAGNESIUM SULPHATE A 1800 MG |
E1343 |
Old Medicine |
1972/09/08 |
Registered
|
info |
| M I DESATNIK |
OMEGA SEJESO MIXTURE |
30 ML
MAGNESIUM SULPHATE A 1800 MG |
E1345 |
Old Medicine |
1972/09/08 |
Registered
|
info |
| M I DESATNIK |
OMEGA COUGH MIXTURE |
5 ML
IPECACUANHA TINCTURE A 0,4 ML
MENTHOL A 50 MG |
G0786 |
Old Medicine |
1974/08/10 |
Registered
|
info |
| M I DESATNIK |
OMEGA FEMALE TONIC |
EACH 5 ML SOLUTION CONTAINS
AROMATIC SPIRIT OF AMMONIA A 0,027 ML
FERRIC AMMONIUM CITRATE A 120 MG |
H0720 |
Old Medicine |
1975/11/01 |
Registered
|
info |
| M I DESATNIK |
OWA PAIN-FREE TABLETS |
TABLET
ASPIRIN 400 MG |
B0978 |
B/2.7/978 |
1984/03/20 |
Registered
|
info |
| M I DESATNIK |
OMEGA KIDNEY AND BLADDER MIXTURE |
EACH 40 ml SOLUTION CONTAINS
POTASSIUM CITRATE A 1920 mg |
H1691 |
Old Medicine |
2000/09/08 |
Registered
|
info |
| Macleods Pharmaceuticals SA (Pty) Ltd |
ORYZYV 600 |
None |
520753.751 |
52/20.1.1/0753.751 |
2021/04/05 |
Registered
|
info |
| Macleods Pharmaceuticals SA (Pty) Ltd |
OTASEL |
None |
520172.171 |
52/20.2.8/0172.171 |
2021/08/17 |
Registered
|
info |
| Macleods Pharmaceuticals SA (Pty) Ltd |
OABMAK CR 7.5 mg |
None |
510614.612 |
51/5.4/0614.612 |
2022/10/05 |
Registered
|
info |
| Macleods Pharmaceuticals SA (Pty) Ltd |
OABMAK CR 15 mg |
None |
510615.613 |
51/5.4/0615.613 |
2022/10/05 |
Registered
|
info |
| Macleods Pharmaceuticals SA (Pty) Ltd |
ORNITRAZ TABLETS |
EACH TABLET CONTAINS
DOLUTEGRAVIR 50,0 mg
LAMIVUDINE 300,0 mg
TENOFOVIR DISOPROXIL FUMARATE 300,0 mg |
520771.77 |
52/20.2.8/0771.770 |
2018/10/10 |
Registered
|
info |
| Macleods Pharmaceuticals SA (Pty) Ltd |
ORIZIT PAED 75/50 |
EACH TABLET CONTAINS
ISONIAZID 50,0 mg
RIFAMPICIN 75,0 mg |
510854.852 |
51/20.2.3/0854.852 |
2018/10/26 |
Registered
|
info |
| MDI HEALTHCARE CC |
ORATEPHLEM |
None |
451126 |
45/10.1/1126 |
2021/07/09 |
Registered
|
info |
| MEDICAL ELECTRONICS (PTY) LTD |
ORGANO DRAINOL |
None |
E1881 |
Old Medicine |
1972/11/09 |
Registered
|
info |
| Mentholatum South Africa |
OXY-5 LOTION |
EACH 25 ml LOTION CONTAINS
BENZOYL PEROXIDE 1,25 g |
N0104 |
N/13.12/104 |
1981/07/27 |
Registered
|
info |
| Mentholatum South Africa |
OXY-10 LOTION |
EACH 25 g CONTAINS
BENZOYL PEROXIDE 2,5 g |
N0112 |
N/13.12/112 |
1982/12/01 |
Registered
|
info |
| Mentholatum South Africa |
OXY MEDICATED PADS |
EACH 100 ml LIQUID CONTAINS
SALICYLIC ACID 0,52 g
TRICLOSAN 0,2 g |
280063 |
28/13.12/0063 |
1995/12/07 |
Registered
|
info |
| Merck (Pty) Ltd |
OVITRELLE 250 ug/0,5 ml |
EACH 0,5 ml SOLUTION CONTAINS
CHORIOGONADOTROPIN ALFA 250,0 ug |
410523 |
41/21.10/0523 |
2012/04/20 |
Registered
|
info |
| MSD (Pty) Ltd |
ONVARA |
EACH 0,5 mL DOSE CONTAINS :
VARICELLA VIRUS NOT LESS THAN 1 350 PFU |
481059 |
48/30.2/1059 |
2016/11/25 |
Registered
|
info |
| MSD (Pty) Ltd |
OMZYTA |
EACH 0,5 ml DOSE CONTAINS :
MEASLES VIRUS NLT 1 000 CCID 50
MUMPS VIRUS NLT 12 500 CCID 50
RUBELLA VIRUS NLT 1 000 CCID 50 |
500576 |
50/30.2/0576 |
2017/09/29 |
Registered
|
info |
| Mundipharma (Pty) Ltd |
OXYNORM 5 mg CAPSULES |
EACH CAPSULE CONTAINS
OXYCODONE HYDROCHLORIDE 5,0 mg |
411103 |
41/2.9/1103 |
2009/08/14 |
#N/A
|
info |
| Mundipharma (Pty) Ltd |
OXYNORM 10 mg CAPSULES |
EACH CAPSULE CONTAINS
OXYCODONE HYDROCHLORIDE 10,0 mg |
411104 |
41/2.9/1104 |
2009/08/14 |
#N/A
|
info |
| Mundipharma (Pty) Ltd |
OXYNORM 20 mg CAPSULES |
EACH CAPSULE CONTAINS
OXYCODONE HYDROCHLORIDE 20,0 mg |
411105 |
41/2.9/1105 |
2009/08/14 |
#N/A
|
info |
| Mundipharma (Pty) Ltd |
OXYCONTIN 5 mg PROLONGED RELEASE TABLETS |
EACH TABLET CONTAINS
OXYCODONE HYDROCHLORIDE 5,0 mg |
411098 |
41/2.9/1098 |
2009/09/10 |
#N/A
|
info |
| Mundipharma (Pty) Ltd |
OXYCONTIN 10 mg PROLONGED RELEASE TABLETS |
EACH TABLET CONTAINS
OXYCODONE HYDROCHLORIDE 10,0 mg |
411099 |
41/2.9/1099 |
2009/09/10 |
#N/A
|
info |
| Mundipharma (Pty) Ltd |
OXYCONTIN 20 mg PROLONGED RELEASE TABLETS |
EACH TABLET CONTAINS
OXYCODONE HYDROCHLORIDE 20,0 mg |
411100 |
41/2.9/1100 |
2009/09/10 |
#N/A
|
info |
| Mundipharma (Pty) Ltd |
OXYCONTIN 40 mg PROLONGED RELEASE TABLETS |
EACH TABLET CONTAINS
OXYCODONE HYDROCHLORIDE 40,0 mg |
411101 |
41/2.9/1101 |
2009/09/10 |
#N/A
|
info |
| Mundipharma (Pty) Ltd |
OXYCONTIN 80 mg PROLONGED RELEASE TABLETS |
EACH TABLET CONTAINS
OXYCODONE HYDROCHLORIDE 80,0 mg |
411102 |
41/2.9/1102 |
2009/09/10 |
#N/A
|
info |
| Mundipharma (Pty) Ltd |
OXYNORM 10 mg INJECTION |
EACH AMPOULE CONTAINS
OXYCODONE HYDROCHLORIDE 10,0 mg |
460718 |
46/2.9/0718 |
2016/09/30 |
Registered
|
info |
| Mundipharma (Pty) Ltd |
OXYNORM 20 mg INJECTION |
EACH AMPOULE CONTAINS
OXYCODONE HYDROCHLORIDE 20,0 mg |
460719 |
46/2.9/0719 |
2016/09/30 |
Registered
|
info |
| Mylan Pharmaceuticals (Pty) Ltd |
OGIVRI 150 |
EACH VIAL CONTAINS :
TRASTUZUMAB 150,0 mg |
520215.213 |
52/26/0215.213 |
2019/05/15 |
Registered
|
info |
| Mylan Pharmaceuticals (Pty) Ltd |
OGIVRI 420 |
EACH VIAL CONTAINS :
TRASTUZUMAB 440,0 mg |
520216.214 |
52/26/0216.214 |
2019/05/15 |
Registered
|
info |
| Mylan Pharmaceuticals (Pty) Ltd |
ODYSTRA |
EACH TABLET CONTAINS
DOLUTEGRAVIR 50,0 mg
LAMIVUDINE 300,0 mg
TENOFOVIR DISOPROXIL FUMARATE 300,0 mg |
520201.199 |
52/20.2.8/0201.199 |
2018/08/31 |
Registered
|
info |
| Mylan Pharmaceuticals (Pty) Ltd |
OPTILAST |
EACH 1,0 ml DROPS CONTAIN
AZELASTINE HYDROCHLORIDE 500,0 mg |
360011 |
36/15.4/0011 |
2005/11/02 |
#N/A
|
info |
| Mylan Pharmaceuticals (Pty) Ltd |
ORALCON |
EACH PACK CONTAINS
ETHINYLESTRADIOL A
LEVONORGESTREL A |
A400693 |
A40/18.8/0693 |
2009/12/06 |
Registered
|
info |
| Mylan Pharmaceuticals (Pty) Ltd |
ODINSTI DISPERSIBLE TABLETS |
None |
560018 |
56/20.2.8/0018 |
2022/06/21 |
Registered
|
info |
| Novartis South Africa (Pty) Ltd |
ONBREZ BREEZHALER 150 ug |
EACH CAPSULE CONTAINS
INDACATEROL MALEATE EQUIVALENT TO INDACATEROL 150,0 ug |
440544 |
44/10.2.1/0544 |
2012/07/06 |
#N/A
|
info |
| Novo Nordisk (Pty) Ltd û (Rivonia) |
OZEMPIC |
EACH 1,0 ml SOLUTION CONTAINS
SEMAGLUTIDE 1,34 mg |
530497 |
53/21.13/0497 |
2020/07/07 |
Registered
|
info |
| O'BRIEN DUTCH REMEDY (PTY)LTD * |
O'BRIEN DUTCH REMEDY |
None |
G0558 |
Old Medicine |
1974/07/08 |
Registered
|
info |
| Octapharma South Africa (Pty) Ltd |
OCTAPLEX 500 IU |
EACH 1,0 ml SOLUTION CONTAINS
HUMAN PROTEIN C 13-31 IU |
520357 |
52/30.3/0357 |
2020/03/24 |
Registered
|
info |
| Octapharma South Africa (Pty) Ltd |
OCTAPLASLG |
EACH 1,0 ml SOLUTION CONTAINS
HUMAN PLASMA PROTEIN 45-70 mg (ABO - blood group) |
520722 |
52/30.3/0722 |
2020/07/04 |
Registered
|
info |
| Octapharma South Africa (Pty) Ltd |
OCTANORM |
EACH 1,0 ml SOLUTION CONTAINS
NORMAL HUMAN IMMUNOGLOBULIN G 165,0 mg |
510731 |
51/30.1/0731 |
2020/06/23 |
Registered
|
info |
| Octapharma South Africa (Pty) Ltd |
OCTANATE 1000 |
EACH VIAL CONTAINS
FACTOR VIII HUMAN 1 000,0 iu |
360346 |
36/30.2/0346 |
2008/08/02 |
#N/A
|
info |
| Octapharma South Africa (Pty) Ltd |
OCTANATE 250 |
EACH VIAL CONTAINS
FACTOR VIII HUMAN 250,0 iu |
360344 |
36/30.3/0344 |
2008/08/02 |
#N/A
|
info |
| Octapharma South Africa (Pty) Ltd |
OCTANATE 500 |
EACH VIAL CONTAINS
FACTOR VIII HUMAN 500,0 iu |
360345 |
36/30.3/0345 |
2008/08/02 |
#N/A
|
info |
| Octapharma South Africa (Pty) Ltd |
OCTANINE F 250 |
EACH 1,0 ml SOLUTION CONTAINS
FACTOR IX HUMAN 50,0 iu |
370645 |
37/30.3/0645 |
2008/08/02 |
#N/A
|
info |
| Octapharma South Africa (Pty) Ltd |
OCTANINE F 500 |
EACH 1,0 ml SOLUTION CONTAINS
FACTOR IX HUMAN 100,0 iu |
370646 |
37/30.3/0646 |
2008/08/02 |
#N/A
|
info |
| Octapharma South Africa (Pty) Ltd |
OCTANINE F 1000 |
EACH 1,0 ml SOLUTION CONTAINS
FACTOR IX HUMAN 100,0 iu |
370647 |
37/30.3/0647 |
2008/08/02 |
#N/A
|
info |
| Octapharma South Africa (Pty) Ltd |
OCTAGAM |
EACH 1,0 ml SOLUTION CONTAINS
IMMUNOGLOBULIN HUMAN NORMAL 50,0 mg |
340501 |
34/30.2/0501 |
2008/06/13 |
#N/A
|
info |
| Oethmaan Biosims (Pty) Ltd |
OBIMET 500 SR |
None |
480313 |
48/21.2/0313 |
2022/01/25 |
Registered
|
info |
| Oethmaan Biosims (Pty) Ltd |
OSMET 500 SR |
None |
481294 |
48/21.2/1294 |
2022/01/25 |
Registered
|
info |
| Oethmaan Biosims (Pty) Ltd |
OBIDENT 500 TABLETS |
None |
470931 |
47/2.7/0931 |
2022/02/28 |
Registered
|
info |
| Oethmaan Biosims (Pty) Ltd |
OBKEF 1g Injection |
None |
471245 |
47/20.1.1/1245 |
2021/08/17 |
Registered
|
info |
| Oethmaan Biosims (Pty) Ltd |
OBKEF 250mg Injection |
None |
490416 |
49/20.1.1/0416 |
2021/08/17 |
Registered
|
info |
| Oethmaan Biosims (Pty) Ltd |
OBKEF 500 mg Injection |
None |
490417 |
49/20.1.1/0417 |
2021/08/17 |
Registered
|
info |
| Oethmaan Biosims (Pty) Ltd |
OXYBUTYNIN 5 OETHMAAN |
EACH TABLET CONTAINS
OXYBUTYNIN HYDROCHLORIDE 5,0 mg |
330359 |
33/5.4/0359 |
2002/09/19 |
#N/A
|
info |
| Oethmaan Biosims (Pty) Ltd |
ONDANTOR 4 mg/2 ML |
EACH 2,0 ml AMPOULE CONTAINS
ONDANSETRON HYDROCHLORIDE DIHYDRATE EQUIVALENT TO ONDANSETRON 4,0 mg |
A390573 |
A39/5.10/0573 |
2006/07/04 |
Registered
|
info |
| Oethmaan Biosims (Pty) Ltd |
ONDANTOR 8 mg/4 ML |
EACH 4,0 ml AMPOULE CONTAINS
ONDANSETRON HYDROCHLORIDE DIHYDRATE EQUIVALENT TO ONDANSETRON 8,0 mg |
A390574 |
A39/5.10/0574 |
2006/07/04 |
Registered
|
info |
| Oethmaan Biosims (Pty) Ltd |
ONDANTOR 4 |
EACH TABLET CONTAINS
ONDANSETRON HYDROCHLORIDE DIHYDRATE EQUIVALENT TO ONDANSETRON 4,0 mg |
A390557 |
A39/5.10/0557 |
2006/07/07 |
Registered
|
info |
| Oethmaan Biosims (Pty) Ltd |
ONDANTOR 8 |
EACH TABLET CONTAINS
ONDANSETRON HYDROCHLORIDE DIHYDRATE EQUIVALENT TO ONDANSETRON 8,0 mg |
A390558 |
A39/5.10/0558 |
2006/07/07 |
Registered
|
info |
| Oethmaan Biosims (Pty) Ltd |
OZTRAK 37.5/325 |
None |
471054 |
47/2.9/1054 |
2022/05/18 |
Registered
|
info |
| Oethmaan Biosims (Pty) Ltd |
OBIRAN 1 g |
None |
490419 |
49/20.1.1/0419 |
2021/11/16 |
Registered
|
info |
| ORCHID PHARMACEUTICALS SA (PTY) LTD |
ORCHID-CEFPODOXIME 100 mg |
EACH TABLET CONTAINS
CEFPODOXIME PROXETIL EQUIVALENT TO CEFPODOXIME 100,0 mg |
430012 |
43/20.1.1/0012 |
2013/10/10 |
#N/A
|
info |
| Organon South Africa (Pty) Ltd |
ORGALUTRAN 0,25 mg |
EACH 0,5 ml SOLUTION CONTAINS
GANIRELIX ACETATE 0,25 mg |
460558 |
46/21.10/0558 |
2016/07/29 |
Registered
|
info |
| Pfizer Laboratories (Pty) Ltd |
ORBENIN DC |
EACH 3 g SYRINGE CONTAINS
CLOXACILLIN BENZATHINE A EQUIVALENT TO CLOXACILLIN 500 mg |
83/368 |
Old Medicine |
1986/10/31 |
Registered
|
info |
| Pfizer Laboratories (Pty) Ltd |
OLBETAM |
EACH CAPSULE CONTAINS
ACIPIMOX 250,0 mg |
W0365 |
W/7.5/365 |
1991/01/10 |
Registered
|
info |
| Eurolab (Pty) Ltd |
ONICIT |
EACH 1,0 ml SOLUTION CONTAINS
PALONOSETRON HYDROCHLORIDE EQUIVALENT TO PALONOSETRON 50,0 ug |
A400322 |
A40/5.10/0322 |
2006/01/12 |
Registered
|
info |
| Pfizer Laboratories (Pty) Ltd |
ORZID 2 g |
EACH VIAL CONTAINS
CEFTAZIDIME 2,0 g |
410873 |
41/20.1.1/0873 |
2008/04/18 |
#N/A
|
info |
| Pfizer Laboratories (Pty) Ltd |
ORCHID-CEFUROXIME 750 mg |
EACH 20,0 ml VIAL CONTAINS
CEFUROXIME SODIUM EQUIVALENT TO CEFUROXIME 750,0 mg |
430259 |
43/20.1.1/0259 |
2015/01/10 |
#N/A
|
info |
| Pharma Dynamics (Pty) Ltd |
OCUTRA |
None |
510099 |
51/15.4/0099 |
2020/04/14 |
Registered
|
info |
| Pharma Dynamics (Pty) Ltd |
OSTEONATE 70 mg |
EACH TABLET CONTAINS
ALENDRONATE SODIUM EQUIVALENT TO ALENDRONIC ACID 70,0 mg |
420235 |
42/3.2/0235 |
2010/11/26 |
Registered
|
info |
| Pharma Dynamics (Pty) Ltd |
OCUDOR CO |
EACH 1,0 ml SOLUTION CONTAINS
DORZOLAMIDE HYDROCHLORIDE EQUIVALENT TO 20,0 mg
TIMOLOL MALEATE EQUIVALENT TO TIMOLOL 5,0 mg |
510162 |
51/15.4/0162 |
2017/11/23 |
Registered
|
info |
| Pharma Dynamics (Pty) Ltd |
OCUBIM 0,01 % |
None |
510055 |
51/15.4/0055 |
2022/06/14 |
Registered
|
info |
| Pharma Dynamics (Pty) Ltd |
OCUBIM 0,03 % |
None |
510056 |
51/15.4/0056 |
2022/06/14 |
Registered
|
info |
| Pharma Dynamics (Pty) Ltd |
OSTEONATE PLUS 2800 ONCE A WEEK |
None |
500636 |
50/3.2/0636 |
2022/06/28 |
Registered
|
info |
| Pharma Dynamics (Pty) Ltd |
OSTEONATE PLUS 5600 ONCE A WEEK |
None |
500637 |
50/3.2/0637 |
2022/06/28 |
Registered
|
info |
| Pharma Dynamics (Pty) Ltd |
OCUCON |
None |
510137 |
51/15.1/0137 |
2021/02/11 |
Registered
|
info |
| PHARMA NATURA (PTY) LTD |
OLBAS |
None |
F0819 |
Old Medicine |
1978/09/30 |
Registered
|
info |
| PHARMA NATURA (PTY) LTD |
OLEUM RHINALE |
None |
F0786 |
Old Medicine |
1978/09/30 |
Registered
|
info |
| Pharmacare Limited û Woodmead |
OGRAVIA 75 mg |
EACH TABLET CONTAINS
CLOPIDOGREL HYDROGEN SULPHATE EQUIVALENT TO CLOPIDOGREL 75,0 mg |
450288 |
45/8.2/0288 |
2016/02/18 |
#N/A
|
info |
| Pharmacare Limited û Woodmead |
ONE DAY FLU CURE |
EACH 5 ML CONTAINS
CINNAMON OIL A 0,09376 ML |
C0566 |
Old Medicine |
1976/08/27 |
Registered
|
info |
| Pharmacare Limited û Woodmead |
OTONE |
EACH TABLET CONTAINS
OXYPHENBUTAZONE 100 mg |
J0251 |
J/3.1/251 |
1978/03/10 |
Registered
|
info |
| Pharmacare Limited û Woodmead |
OPTALLERG |
EACH 10 CONTAINS
ANTAZOLINE SULFATE 50 mg
NAPHAZOLINE NITRATE 2,5 mg |
L0386 |
L/15.4/386 |
1980/05/23 |
Registered
|
info |
| Pharmacare Limited û Woodmead |
OLIVE OIL |
EACH BOTTLE CONTAINS
OLIVE OIL A |
BV164 |
Old Medicine |
1987/02/24 |
Registered
|
info |
| Pharmacare Limited û Woodmead |
OROCHLOR |
EACH 100 ml SOLUTION CONTAINS
BENZOCAINE 266,667 mg
CHLORHEXIDINE GLUCONATE SOLUTION 20 % 1 ml |
P0041 |
P/16.3/41 |
1981/11/20 |
Registered
|
info |
| Pharmacare Limited û Woodmead |
OXYMYCIN |
EACH CAPSULE CONTAINS
OXYTETRACYCLINE HYDROCHLORIDE EQUIVALENT TO 250 mg OXYTETRACYCLINE |
P0130 |
P/20.1.1/130 |
1982/03/15 |
Registered
|
info |
| Pharmacare Limited û Woodmead |
OROSOOTHE |
EACH LOZENGE CONTAINS
BENZOCAINE 10 mg
DEQUALINIUM CHLORIDE O,25 mg |
V0073 |
V/16.4/73 |
1988/04/02 |
Registered
|
info |
| Pharmacare Limited û Woodmead |
OROCHLOR SPRAY SOLUTION |
EACH 100 ml SOLUTION CONTAINS
BENZOCAINE 266,625 mg
CHLORHEXIDINE GLUCONATE SOLUTION 1,071425 ml |
280057 |
28/16.3/0057 |
1994/07/02 |
#N/A
|
info |
| Pharmacare Limited û Woodmead |
OMRASTOZ 150 mg |
EACH 1 ML AMPOULE CONTAINS
MEDROXYPROGESTERONE ACETATE 150 MG |
280202 |
28/21.8.2/0202 |
1994/02/24 |
Registered
|
info |
| Pharmacare Limited û Woodmead |
OCULERGE |
EACH 1 ml LIQIUD CONTAINS
ANTAZOLINE HYDROCHLORIDE 0,5 mg
TETRAHYDROZOLINE HYDROCHLORIDE 0,4 mg |
310144 |
31/15.4/0144 |
1997/08/04 |
#N/A
|
info |
| Pharmacare Limited û Woodmead |
OSSIPLEX RETARD |
EACH TABLET CONTAINS
SODIUM FLUORIDE 25 mg
VITAMIN C 200 mg |
W0223 |
W/3.2/0223 |
1998/04/17 |
Registered
|
info |
| PHARMACHEM PHARMACEUTICALS CC |
ORMODON |
EACH TABLET CONTAINS
NITRAZEPAM 5 mg |
K0140 |
K/2.2/140 |
1977/02/02 |
Registered
|
info |
| Pharmacorp (Pty) Ltd |
ONDANSETRON 4 mg/2 ML PHARM C |
EACH 1,0 ml LIQUID CONTAINS
ONDANSETRON HYDROCHLORIDE EQUIVALENT TO ONDANSETRON 2,0 mg |
A390062 |
A39/5.10/0062 |
2005/11/25 |
Registered
|
info |
| Pharmacorp (Pty) Ltd |
ONDANSETRON 8 mg/4 ML PHARM C |
EACH 1,0 ml LIQUID CONTAINS
ONDANSETRON HYDROCHLORIDE EQUIVALENT TO ONDANSETRON 2,0 mg |
A390063 |
A39/5.10/0063 |
2005/11/25 |
Registered
|
info |
| Pharmacorp (Pty) Ltd |
OCTREOTIDE 0,05 mg/ML PHARMC |
None |
481083 |
48/34/1083 |
2022/06/14 |
Registered
|
info |
| Pharmacorp (Pty) Ltd |
OCTREOTIDE 0,1 mg/ML PHARMC |
None |
481084 |
48/34/1084 |
2022/06/14 |
Registered
|
info |
| Pharmaplan (Pty) Ltd |
ORATANE 10 mg |
EACH CAPSULE CONTAINS
ISOTRETINOIN 10,0 mg |
350375 |
35/13.4.2/0375 |
2003/04/25 |
Registered
|
info |
| Pharmaplan (Pty) Ltd |
ORATANE 20 mg |
EACH CAPSULE CONTAINS
ISOTRETINOIN 20,0 mg |
350376 |
35/13.4.2/0376 |
2003/04/25 |
#N/A
|
info |
| Pharmaplan (Pty) Ltd |
OMSAL CAPSULES |
EACH CAPSULE CONTAINS
TAMSULOSIN HYDROCHLORIDE 0,4 mg |
420538 |
42/18.10/0538 |
2012/07/12 |
Registered
|
info |
| Pharma-Q Holdings (Pty) Ltd |
OTI-EZZE |
EACH 10,0 ml LIQUID CONTAINS
BENZOCAINE A 0,1 g
CHLORBUTOL A 0,1 g
PHENAZONE A 0,5 g |
H1453 |
Old Medicine |
1975/04/02 |
Canceled
|
info |
| Pharma-Q Holdings (Pty) Ltd |
ORITAXIM 500 |
EACH VIAL CONTAINS
CEFOTAXIME SODIUM EQUIVALENT TO CEFOTAXIME 500,0 mg |
360482 |
36/20.1.1/0482 |
2004/12/11 |
#N/A
|
info |
| Pharma-Q Holdings (Pty) Ltd |
ORITAXIM 1000 |
EACH VIAL CONTAINS
CEFOTAXIME SODIUM EQUIVALENT TO CEFOTAXIME 1000,0 mg |
360483 |
36/20.1.1/0483 |
2004/12/11 |
#N/A
|
info |
| PHENIX SA (PTY) LTD |
OTOSPECTRINE EARDROPS |
EACH 1 ml SUSPENSION CONTAINS
DEXAMETHASONE A 1 mg
LIDOCAINE HYDROCHLORIDE A 40 mg
NEOMYCIN SULPHATE A 5 000 IU
POLYMYXIN B SULFATE A 10 000 IU
SULFIRAM A 50 mg |
83/287 |
Old Medicine |
1984/04/16 |
Registered
|
info |
| PHENIX SA (PTY) LTD |
OXYVITAL |
EACH 1 g POWDER CONTAINS
CALCIUM PANTOTHENATE A 5 mg
FURALTADONE HYDROCHLORIDE A 10 mg
FURAZOLIDONE A 10 mg
MENADIONE SODIUM BISULFITE A 2 mg
NICOTINAMIDE A 15 mg
OXYTETRACYCLINE HYDROCHLORIDE A EQUIVALENT TO OXYTETRACYCLINE |
83/303 |
Old Medicine |
1984/04/16 |
Registered
|
info |
| Ranbaxy (SA) (Pty) Ltd û Centurion |
OLEANZ RAPITAB 5 |
EACH TABLET CONTAINS
OLANZAPINE 5,0 mg |
430069 |
43/2.6.5/0069 |
2011/04/15 |
#N/A
|
info |
| Ranbaxy (SA) (Pty) Ltd û Centurion |
OLEANZ RAPITAB 10 |
EACH TABLET CONTAINS
OLANZAPINE 10,0 mg |
430070 |
43/2.6.5/0070 |
2011/04/15 |
#N/A
|
info |
| Ranbaxy (SA) (Pty) Ltd û Centurion |
OLEANZ 2,5 |
EACH TABLET CONTAINS
OLANZAPINE 2,5 mg |
430326 |
43/2.6.5/0326 |
2011/05/08 |
#N/A
|
info |
| Ranbaxy (SA) (Pty) Ltd û Centurion |
OLEANZ 5 |
EACH TABLET CONTAINS
OLANZAPINE 5,0 mg |
430327 |
43/2.6.5/0327 |
2011/05/08 |
#N/A
|
info |
| Ranbaxy (SA) (Pty) Ltd û Centurion |
OLEANZ 10 |
EACH TABLET CONTAINS
OLANZAPINE 10,0 mg |
430328 |
43/2.6.5/0328 |
2011/05/08 |
#N/A
|
info |
| Ranbaxy (SA) (Pty) Ltd û Centurion |
OLASKIT 2,5 |
EACH TABLET CONTAINS
OLANZAPINE 2,5 mg |
430870 |
43/2.6.5/0870 |
2013/08/15 |
#N/A
|
info |
| Ranbaxy (SA) (Pty) Ltd û Centurion |
OLASKIT 5 |
EACH TABLET CONTAINS
OLANZAPINE 5,0 mg |
430871 |
43/2.6.5/0871 |
2013/08/15 |
#N/A
|
info |
| Ranbaxy (SA) (Pty) Ltd û Centurion |
OLASKIT 10 |
EACH TABLET CONTAINS
OLANZAPINE 10,0 mg |
430872 |
43/2.6.5/0872 |
2013/08/15 |
#N/A
|
info |
| Ranbaxy (SA) (Pty) Ltd û Centurion |
ONCOMAM |
EACH TABLET CONTAINS
ANASTROZOLE 1,0 mg |
440566 |
44/21.12/0566 |
2014/07/31 |
#N/A
|
info |
| RHONE-POULENC ANIMAL HEALTH SA (PTY) LTD |
ORALJECT P - BUTAZONE |
EACH 5 ML PASTE CONTAINS
PHENYLBUTAZONE A 1,0 g |
83/713 |
Old Medicine |
1984/04/16 |
Registered
|
info |
| RHONE-POULENC ANIMAL HEALTH SA (PTY) LTD |
ORAJECT ORABOL H |
EACH 100 G CONTAINS
METHANDRIOL A 2,0 g AS DIPROPIONATE |
83/712 |
Old Medicine |
1986/10/23 |
Registered
|
info |
| RHONE-POULENC ANIMAL HEALTH SA (PTY) LTD |
ORAJECT SEDAZINE ACP |
EACH 100 G CONTAINS
ACEPROMAZINE MALEATE A 60,0 mg |
83/715 |
Old Medicine |
1986/10/23 |
Registered
|
info |
| Roche Products (Pty) Ltd |
OCREVUS |
EACH 10,0 ml SOLUTION CONTAINS
OCRELIZUMAB 300,0 mg |
520581 |
52/30.1/0581 |
2020/07/14 |
Registered
|
info |
| Safeline Pharmaceuticals (Pty) Ltd |
OXAVIATIN 50 mg/10 ml |
EACH 10,0 ml SOLUTION CONTAINS
OXALIPLATIN 50,0 mg |
450934 |
45/26/0934 |
2018/11/06 |
#N/A
|
info |
| Safeline Pharmaceuticals (Pty) Ltd |
OXAVIATIN 100 mg/20 ml |
EACH 20,0 ml SOLUTION CONTAINS
OXALIPLATIN 100,0 mg |
450935 |
45/26/0935 |
2018/11/06 |
#N/A
|
info |
| Safeline Pharmaceuticals (Pty) Ltd |
OXAVIATIN 200 mg/40 ml |
EACH 40,0 ml SOLUTION CONTAINS
OXALIPLATIN 200,0 mg |
450936 |
45/26/0936 |
2018/11/06 |
#N/A
|
info |
| Safeline Pharmaceuticals (Pty) Ltd |
ONDANSETRON SAFELINE 4 mg INJECTION |
EACH 2,0 ml AMPOULE CONTAINS
ONDANSETRON HYDROCHLORIDE DIHYDRATE EQUIVALENT TO ONDANSETRON 4,0 mg |
410241 |
41/5.10/0241 |
2012/07/27 |
Registered
|
info |
| Safeline Pharmaceuticals (Pty) Ltd |
ONDANSETRON SAFELINE 8 mg INJECTION |
EACH 4,0 ml AMPOULE CONTAINS
ONDANSETRON HYDROCHLORIDE DIHYDRATE EQUIVALENT TO ONDANSETRON 8,0 mg |
410242 |
41/5.10/0242 |
2012/07/27 |
Registered
|
info |
| Safeline Pharmaceuticals (Pty) Ltd |
OMEPRAZOLE-SAFELINE INJECTION 40 mg |
EACH VIAL CONTAINS
OMEPRAZOLE SODIUM EQUIVALENT TO OMEPRAZOLE 40,0 mg |
420515 |
42/11.4.3/0515 |
2012/07/12 |
#N/A
|
info |
| Ascendis Pharma (Pty) Ltd |
OMILOC 40 IVI |
EACH VIAL CONTAINS
OMEPRAZOLE 40,0 mg |
420600 |
42/11.4.3/0600 |
2010/03/19 |
Registered
|
info |
| Sandoz South Africa (Pty) Ltd |
OMNITROPE 5 mg/1,5 ml |
EACH 1,5 mL SOLUTION CONTAINS
SOMATROPIN 5,0 mg |
490735.732 |
49/21.10/0735.732 |
2020/03/17 |
Registered
|
info |
| Sandoz South Africa (Pty) Ltd |
OMNITROPE 10 mg/1,5 ml |
EACH 1,5 mL SOLUTION CONTAINS
SOMATROPIN 10,0 mg |
490736.733 |
49/21.10/0736.733 |
2020/03/17 |
Registered
|
info |
| Sandoz South Africa (Pty) Ltd |
OMNITROPE 15 mg/1,5 ml |
EACH 1,5 mL SOLUTION CONTAINS
SOMATROPIN 15,0 mg |
490737.734 |
49/21.10/0737.734 |
2020/03/17 |
Registered
|
info |
| Sandoz South Africa (Pty) Ltd |
OREOXAL 40 mg/5 ml |
EACH 5,0 ml SUSPENSION CONTAINS
CEFPODOXIME PROXETIL EQUIVALENT TO CEFPODOXIME 40,0 mg |
A400734 |
A40/20.1.1/0734 |
2008/08/15 |
Registered
|
info |
| Sandoz South Africa (Pty) Ltd |
OMIFLUX 20 |
EACH CAPSULE CONTAINS
OMEPRAZOLE 20,0 mg |
430457 |
43/11.4.3/0457 |
2014/05/06 |
#N/A
|
info |
| Sandoz South Africa (Pty) Ltd |
OXYMETAZOLINE SANDOZ P 0,025 NASAL DROPS |
EACH 1,0 ml DROPS CONTAINS
OXYMETAZOLINE 0,25 mg |
440747 |
44/16.1/0747 |
2014/05/06 |
#N/A
|
info |
| Sandoz South Africa (Pty) Ltd |
OXYMETAZOLINE SANDOZ 0,05 % NASAL DROPS |
EACH 1,0 ml DROPS CONTAINS
OXYMETAZOLINE 0,5 mg |
440748 |
44/16.1/0748 |
2014/05/06 |
#N/A
|
info |
| Sandoz South Africa (Pty) Ltd |
OXALIPLATIN "EBEWE" 50 mg |
EACH VIAL CONTAINS
OXALIPLATIN 50,0 mg |
410910 |
41/26/0910 |
2016/09/06 |
#N/A
|
info |
| Sandoz South Africa (Pty) Ltd |
OXALIPLATIN "EBEWE" 100 mg |
EACH VIAL CONTAINS
OXALIPLATIN 100,0 mg |
411129 |
41/26/1129 |
2016/09/06 |
#N/A
|
info |
| Sanofi-Aventis South Africa (Pty) Ltd |
ORELOX 100 |
EAHC TABLET CONTAINS
CEFPODOXIME PROXETIL EQUIVALENT TO 100 mg CEFPODOXIME |
Z0007 |
Z/20.1.1/7 |
1991/09/09 |
Registered
|
info |
| Sanofi-Aventis South Africa (Pty) Ltd |
ORELOX-JUNIOR |
EACH 5 ml SUSPENSION CONTAINS
CEFPODOXIME PROXETIL EQUIVALENT TO 40 mg CEFPODOXIME |
270564 |
27/20.1.1/0564 |
1993/10/11 |
#N/A
|
info |
| Sanofi-Aventis South Africa (Pty) Ltd |
OPTISON |
EACH 1,0 ml SUSPENSION CONTAINS
ALBUMIN (HUMAN) CONTAINING OCTAFLUOROPROPANE 1 % |
340075 |
34/28/0075 |
2001/07/31 |
#N/A
|
info |
| Sanofi-Aventis South Africa (Pty) Ltd |
OXALIWIN 50 mg/10 ml |
EACH 1,0 ml SOLUTION CONTAINS
OXALIPLATIN 5,0 mg |
A390519 |
A39/26/0519 |
2007/05/10 |
Registered
|
info |
| Sanofi-Aventis South Africa (Pty) Ltd |
OXALIWIN 50 mg/10 ml RTU |
EACH 1,0 ml SOLUTION CONTAINS
OXALIPLATIN 5,0 mg |
A390521 |
A39/26/0521 |
2007/05/10 |
Registered
|
info |
| Sanofi-Aventis South Africa (Pty) Ltd |
OXALIWIN 100 mg/20 ml RTU |
EACH 1,0 ml SOLUTION CONTAINS
OXALIPLATIN 5,0 mg |
A390522 |
A39/26/0522 |
2007/05/10 |
Registered
|
info |
| Sanofi-Aventis South Africa (Pty) Ltd |
OXALIWIN 100 mg/20 ml |
EACH 1,0 ml SOLUTION CONTAINS
OXALIPLATIN 5,0 mg |
A390520 |
A390520 |
2007/05/10 |
Registered
|
info |
| Sanofi-Aventis South Africa (Pty) Ltd |
ORELOX 200 |
EACH TABLET CONTAINS
CEFPODOXIME PROXETIL EQUIVALENT TO CEFPODOXIME 200,0 mg |
A380406 |
A38/20.1.1/0406 |
2009/12/06 |
Registered
|
info |
| SC JOHNSON WAX |
OFF KIDS |
EACH 1,0 g LIQUID CONTAINS
DIETHYLTOLUAMIDE 50,0 mg |
300491 |
30/34/0491 |
1999/06/18 |
#N/A
|
info |
| SC JOHNSON WAX |
OFF AEROSOL |
EACH 1,0 g SOLUTION CONTAINS
DIETHYLTOLUAMIDE 150,0 mg |
310055 |
31/34/0055 |
1999/06/18 |
#N/A
|
info |
| Strides Pharma (SA) (Pty) Ltd |
OSTEOBON-10 |
EACH TABLET CONTAINS
ALENDRONATE SODIUM EQUIVALENT TO ALENDRONIC ACID 10,0 mg |
A390243 |
A39/3.2/0243 |
2004/10/22 |
Registered
|
info |
| Strides Pharma (SA) (Pty) Ltd |
OSELFLU |
EACH CAPSULE CONTAINS
OSELTAMIVIR PHOSPHATE EQUIVALENT TO OSELTAMIVIR 75,0 mg |
410798 |
41/20.2.8/0798 |
2009/05/03 |
#N/A
|
info |
| SVIZERA SA (PTY) LTD |
OFRAMAX 250 |
EACH VIAL CONTAINS
CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 250,0 mg |
340318 |
34/20.1.1/0318 |
2001/04/10 |
#N/A
|
info |
| SVIZERA SA (PTY) LTD |
OFRAMAX 1 g |
EACH VIAL CONTAINS
CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1,0 g |
340319 |
34/20.1.1/0319 |
2001/04/10 |
#N/A
|
info |
| Teva Pharmaceuticals (Pty) Ltd |
OCTREOTIDE TEVA 10 mg |
EACH VIAL CONTAINS
OCTREOTIDE 10,0 mg |
540425 |
54/34/0425 |
2021/02/03 |
Registered
|
info |
| Teva Pharmaceuticals (Pty) Ltd |
OCTREOTIDE TEVA 20 mg |
EACH VIAL CONTAINS
OCTREOTIDE 20,0 mg |
540426 |
54/34/0426 |
2021/02/03 |
Registered
|
info |
| Teva Pharmaceuticals (Pty) Ltd |
OCTREOTIDE TEVA 30 mg |
EACH VIAL CONTAINS
OCTREOTIDE 30,0 mg |
540427 |
54/34/0427 |
2021/02/03 |
Registered
|
info |
| Teva Pharmaceuticals (Pty) Ltd |
OCUPROST |
EACH 1,0 ml SOLUTION CONTAINS
LATANOPROST 50,0 ug |
380185 |
38/15.4/0185 |
2005/03/06 |
#N/A
|
info |
| Teva Pharmaceuticals (Pty) Ltd |
OXALIPLATIN PCH 50 |
EACH 10,0 ml VIAL CONTAINS
OXALIPLATIN 50,0 mg |
430102 |
43/26/0102 |
2012/07/27 |
Registered
|
info |
| Teva Pharmaceuticals (Pty) Ltd |
OXALIPLATIN PCH 100 |
EACH 20,0 ml VIAL CONTAINS
OXALIPLATIN 100,0 mg |
430103 |
43/26/0103 |
2012/07/27 |
Registered
|
info |
| THE PREMIER PHARMACEUTICAL CO LTD |
OXYPAN I V 500 MG |
INJECTION
OXYTETRACYCLINE A 551 MG / 15 ML |
A0671 |
Old Medicine |
1968/06/06 |
Registered
|
info |
| THE PREMIER PHARMACEUTICAL CO LTD |
ORPADREX |
TABLET
ORPHENADRINE HYDROCHLORIDE A 50 MG |
C0675 |
Old Medicine |
1970/09/18 |
Registered
|
info |
| THE PREMIER PHARMACEUTICAL CO LTD |
OXYPAN IM 50 mg* |
EACH 1 ml SOLUTION CONTAINS
OXYTETRACYCLINE 50 mg |
F0098 |
F/20.1.1/98 |
1974/06/19 |
Registered
|
info |
| THE PREMIER PHARMACEUTICAL CO LTD |
OTISED EAR DROPS |
EACH 1 ml CONTAINS
BENZOCAINE A 0,01 g
PHENAZONE A 0,05 g |
H1418 |
Old Medicine |
1975/02/20 |
Registered
|
info |
| THE PREMIER PHARMACEUTICAL CO LTD |
OPTI-CET |
EACH GRAM CONTAINS
SULFACETAMIDE SODIUM A 100 mg |
H1308 |
Old Medicine |
1975/02/21 |
Registered
|
info |
| THE PREMIER PHARMACEUTICAL CO LTD |
OCUZOL EYE DROPS |
EACH 1 ml CONTAINS
OXYMETAZOLINE HYDROCHLORIDE A 0,5 mg |
H1273 |
Old Medicine |
1975/02/24 |
Registered
|
info |
| THE PREMIER PHARMACEUTICAL CO LTD |
OPTIMED |
EACH 1 ml CONTAINS
PHENYLEPHRINE HYDROCHLORIDE A 12,5 mg |
H1310 |
Old Medicine |
1975/02/24 |
Registered
|
info |
| THE PREMIER PHARMACEUTICAL CO LTD |
OK ANTISEPTIC/OK ANTISEPTIESE* |
EACH 1 ml SOLUTION CONTAINS
CETRIMIDE 30 mg
CHLORHEXIDINE GLUCONATE 3 mg |
Y0423 |
Y/13.1/423 |
1991/11/22 |
Registered
|
info |
| Trinity Pharma (Pty) Ltd |
ONDANSETRON 4 TRINITY |
None |
480776 |
48/5.10/0776 |
2022/07/06 |
Registered
|
info |
| Trinity Pharma (Pty) Ltd |
ONDANSETRON 8 TRINITY |
None |
480777 |
48/5.10/0777 |
2022/07/06 |
Registered
|
info |
| Trinity Pharma (Pty) Ltd |
OMECTRON 4 ODT |
None |
480778 |
48/5.10/0778 |
2022/07/06 |
Registered
|
info |
| Trinity Pharma (Pty) Ltd |
OMECTRON 8 ODT |
None |
480779 |
48/5.10/0779 |
2022/07/06 |
Registered
|
info |
| Trinity Pharma (Pty) Ltd |
OXEBRECO 100 |
None |
490666 |
49/3.1/0666 |
2021/10/19 |
Registered
|
info |
| Trinity Pharma (Pty) Ltd |
OXEBRECO 200 |
None |
490667 |
49/3.1/0667 |
2021/10/19 |
Registered
|
info |
| TRIOMED (PTY) LTD |
OROSEPT |
EACH 100 ml CONTAINS
CHLORHEXIDINE GLUCONATE SOLUTION 20 % m/v 1 ml |
R0220 |
R/16.4/220 |
1986/05/08 |
#N/A
|
info |
| Unicorn Pharmaceuticals (Pty) Ltd |
OLANZAPINE ODT 5 UNICORN |
None |
481037 |
48/2.6.5/1037 |
2021/02/16 |
Registered
|
info |
| Unicorn Pharmaceuticals (Pty) Ltd |
OLANZAPINE ODT 10 UNICORN |
None |
481038 |
48/2.6.5/1038 |
2021/02/16 |
Registered
|
info |
| Unicorn Pharmaceuticals (Pty) Ltd |
OLANZAPINE ODT 15 UNICORN |
None |
481039 |
48/2.6.5/1039 |
2021/02/16 |
Registered
|
info |
| Unicorn Pharmaceuticals (Pty) Ltd |
OLANZAPINE ODT 20 UNICORN |
None |
481040 |
48/2.6.5/1040 |
2021/02/16 |
Registered
|
info |
| Unimed Healthcare (Pty) Ltd |
ORASIL 250 |
None |
500535 |
50/20.1.2/0535 |
2021/04/05 |
Registered
|
info |
| Unimed Healthcare (Pty) Ltd |
ORASIL 500 |
None |
500536 |
50/20.1.2/0536 |
2021/04/05 |
Registered
|
info |
| Upjohn South Africa (Pty) Ltd |
ORBEOS 10 |
EACH TABLET CONTAINS
ATORVASTATIN 10,0 mg |
421050 |
42/7.5/1050 |
2011/04/15 |
#N/A
|
info |
| Upjohn South Africa (Pty) Ltd |
ORBEOS 20 |
EACH TABLET CONTAINS
ATORVASTATIN 20,0 mg |
421051 |
42/7.5/1051 |
2011/04/15 |
#N/A
|
info |
| Upjohn South Africa (Pty) Ltd |
ORBEOS 40 |
EACH TABLET CONTAINS
ATORVASTATIN 40,0 mg |
421052 |
42/7.5/1052 |
2011/04/15 |
#N/A
|
info |
| Viatris South Africa (Pty) Ltd |
ORBEOS 80 |
EACH TABLET CONTAINS
ATORVASTATIN 80,0 mg |
430838 |
43/7.5/0838 |
2014/07/31 |
#N/A
|
info |
| WRENS (PTY) LTD* |
OKASA |
TABLET
ALPHA TOCOPHERYL ACETATE A 0,1 MG
AMMONIUM MOLYBDATE A 0,006 MG
ASCORBIC ACID A 5,0 MG
CALCIUM CITRICUM A 50,0 MG
CALCIUM HYDROGEN PHOSPHATE DIHYDRATE A 30,0 MG
CALCIUM PANTOTHENATE A 0,5 MG
CALCIUM SILICATE A 1,0 MG |
G2472 |
Old Medicine |
1974/11/20 |
Registered
|
info |
| WRENS (PTY) LTD* |
OKASA GOLD |
TABLET
AMMONIUM MOLYBDATE A 0,006 MG
ASCORBIC ACID A 5 MG
CALCIUM CITRICUM A 50 MG
CALCIUM HYDROGEN PHOSPHATE DIHYDRATE A 20 MG
CALCIUM PANTOTHENATE A 0,5 MG
CALCIUM SILICATE A 1 MG
ERGOCALCIFEROL A 0,0025 MG
FERROUS PHOSPH |
G2473 |
Old Medicine |
1974/11/20 |
Registered
|
info |
| ZENTIVA SOUTH AFRICA (PTY) LTD |
OLAWIN ORODISPERSIBLE 10 mg |
EACH TABLET CONTAINS
OLANZAPINE 10,0 mg |
440855 |
44/2.6.5/0855 |
2015/11/06 |
#N/A
|
info |
| ZENTIVA SOUTH AFRICA (PTY) LTD |
OLAWIN FILM COATED 5 mg |
EACH TABLET CONTAINS
OLANZAPINE 5,0 mg |
441020 |
44/2.6.5/1020 |
2015/11/06 |
#N/A
|
info |
| Zimbili Pharma cc |
OLANDUS 2,5 |
EACH TABLET CONTAINS
OLANZAPINE 2,5 mg |
440977 |
44/2.6.5/0977 |
2014/07/31 |
#N/A
|
info |
| Zimbili Pharma cc |
OLANDUS 5 |
EACH TABLET CONTAINS
OLANZAPINE 5,0 mg |
440978 |
44/2.6.5/0978 |
2014/07/31 |
#N/A
|
info |
| Zimbili Pharma cc |
OLANDUS 10 |
EACH TABLET CONTAINS
OLANZAPINE 10,0 mg |
440979 |
44/2.6.5/0979 |
2014/07/31 |
#N/A
|
info |
| Zoetis South Africa (Pty) Ltd |
ORBENIN EXTRA DC |
EACH SYRINGE CONTAINS
CLOXACILLIN BENZATHINE EQUIVALENT TO 600 mg CLOXACILLIN |
91/6 |
91/24.1/6 |
1995/04/01 |
Registered
|
info |
| Zydus Healthcare (Pty) Ltd |
OXYSPRAY MOISTURIZING |
EACH 1,0 ml SOLUTION CONTAINS
OXYMETAZOLINE HYDROCHLORIDE 0,5 mg |
450232 |
45/16.1/0232 |
2015/03/23 |
Registered
|
info |
| Zydus Healthcare (Pty) Ltd |
ONDANSETRON CIPLA IV 4 mg |
EACH 1,0 ml SOLUTION CONTAINS
ONDANSETRON HYDROCHLORIDE EQUIVALENT TO ONDANSETRON 2,0 mg |
A400484 |
A40/5.10/0484 |
2007/02/03 |
Canceled
|
info |
| Zydus Healthcare (Pty) Ltd |
ONDANSETRON CIPLA IV 8 mg |
EACH 1,0 ml SOLUTION CONTAINS
ONDANSETRON HYDROCHLORIDE EQUIVALENT TO ONDANSETRON 2,0 mg |
A400485 |
A40/5.10/0485 |
2007/02/03 |
Canceled
|
info |
| Zydus Healthcare (Pty) Ltd |
ODIVEN 37,5 |
EACH TABLET CONTAINS
VENLAFAXINE 37,5 mg |
410440 |
41/1.2/0440 |
2008/08/15 |
#N/A
|
info |
| Zydus Healthcare (Pty) Ltd |
ODIVEN 50 |
EACH TABLET CONTAINS
VENLAFAXINE 50,0 mg |
410441 |
41/1.2/0441 |
2008/08/15 |
#N/A
|
info |
| Zydus Healthcare (Pty) Ltd |
ODIVEN 75 |
EACH TABLET CONTAINS
VENLAFAXINE 75,0 mg |
410442 |
41/1.2/0442 |
2008/08/15 |
#N/A
|
info |
| Austell Pharmaceuticals (Pty) Ltd |
OFTAPAT |
OLOPATADINE HYDROCHLORIDE |
530401 |
53/15.4/0401 |
2022/10/25 |
Registrered
|
info |
| Soflens (Pty) Ltd |
OPTAGEX |
LEVOCABASTINE |
550427 |
55/5.7.1/0427 |
2022/11/08 |
Registrered
|
info |
| Amgen South Africa (Pty)Ltd |
OTEZLA Starter Pack |
APREMILAST |
560041 |
56/32/0041 |
2022/11/15 |
Registrered
|
info |
| Trinity Pharma (Pty) Ltd |
ONDANSETRON 4 ODT UNICORN |
Each tablet contains ONDANSETRON 4,0 mg |
521012 |
52/5.10/1012 |
2022/06/28 |
Registered
|
info |
| Trinity Pharma (Pty) Ltd |
ONDANSETRON 8 ODT UNICORN |
Each tablet contains ONDANSETRON 8,0 mg |
521013 |
52/5.10/1013 |
2022/06/28 |
Registered
|
info |
| Activo Health (Pty) Ltd |
OXYTOCIN ACTIVO |
Each ampoule contains OXYTOCIN 10,0 IU/ml |
520902 |
52/19/0902 |
2022/12/07 |
Registered
|
info |
| Activo Health (Pty) Ltd |
OXYJECT |
Each ampoule contains OXYTOCIN 10,0 IU/ml |
520903.902 |
52/19/0903.902 |
2022/12/07 |
Registered
|
info |
| iNova Pharmaceuticals (Pty) Ltd |
ONYBAN 5 % |
Each 1 ml lacquer contains AMOROLFINE 50,0 mg |
480207 |
48/13.8.2/0207 |
2022/12/07 |
Registered
|
info |
| Ranbaxy (SA) (Pty) Ltd û Centurion |
OCTUDEX |
Each 1,0 ml contains TOBRAMYCIN 3,0 mg and DEXAMETHASONE 1,0 mg |
511074 |
51/15.3/1074 |
2022/07/19 |
Registered
|
info |
| Mylan Pharmaceuticals (Pty) Ltd |
OSMOLAX |
Each sachet contains MACROGOL (PEG) 13,125 g and SODIUM CHLORIDE 350,7 mg and SODIUM HYDROGEN CARBONATE 178,5 mg and POTASSIUM CHLORIDE 46,6 mg |
480206 |
48/11.5/0206 |
2022/04/08 |
Registered
|
info |
| Unicorn Pharmaceuticals (Pty) Ltd |
OCAZ |
Each active tablet contains DROSPIRENONE 3,0 mg ETHINYL ESTRADIOL 0,03 mg |
470159 |
47/18.8/0159 |
2022/10/08 |
Registered
|
info |
| Pharma-Q Holdings (Pty) Ltd |
OLOPATADINE EYE DROPS PHARMA-Q |
Each 1 ml contains OLOPATADINE HYDROCHLORIDE EQUIVALENT TO OLOPATADINE 1,0 mg |
471125 |
47/15.4/1125 |
2022/10/08 |
Registered
|
info |
| Gen-Eye (Pty) Ltd |
OLOPAGEN |
Each 1 ml contains OLOPATADINE HYDROCHLORIDE EQUIVALENT TO OLOPATADINE 1,0 mg |
491078 |
49/15.4/1078 |
2022/10/08 |
Registered
|
info |
| Pharmacare Limited û Woodmead |
OROTHROAT LEMON LOZENGES |
Each lozenge contains 2,4-DICHLOROBENZYL ALCOHOL 1,2 mg and AMYLMETACRESOL 0,6 mg |
500820 |
50/16.4/0820 |
2022/10/08 |
Registered
|
info |
| Pharmacare Limited û Woodmead |
OROTHROAT BLACKCURRANT LOZENGES |
Each lozenge contains 2,4-DICHLOROBENZYL ALCOHOL 1,2 mg and AMYLMETACRESOL 0,6 mg |
500821 |
50/16.4/0821 |
2022/10/08 |
Registered
|
info |
| Pharmacare Limited û Woodmead |
OROTHROAT HONEY AND LEMON LOZENGES |
Each lozenge contains 2,4-DICHLOROBENZYL ALCOHOL 1,2 mg and AMYLMETACRESOL 0,6 mg |
500822 |
50/16.4/0822 |
2022/10/08 |
Registered
|
info |
| Pharmacare Limited û Woodmead |
OROTHROAT ORANGE LOZENGES |
Each lozenge contains 2,4-DICHLOROBENZYL ALCOHOL 1,2 mg and AMYLMETACRESOL 0,6 mg |
500823 |
50/16.4/0823 |
2022/10/08 |
Registered
|
info |
| Pharmacare Limited û Woodmead |
OROTHROAT PLUS HONEY AND LEMON LOZENGES |
Each lozenge contains 2,4-DICHLOROBENZYL ALCOHOL 1,2 mg AMYLMETACRESOL 0,6 mg and LIDOCAINE HYDROCHLORIDE 10,0 mg |
520125 |
52/16.4/0125 |
2022/10/08 |
Registered
|
info |
| Pharmacare Limited û Woodmead |
OROTHROAT PLUS BLACKCURRANT LOZENGES |
Each lozenge contains 2,4-DICHLOROBENZYL ALCOHOL 1,2 mg and AMYLMETACRESOL 0,6 mg and LIDOCAINE HYDROCHLORIDE 10,0 mg |
520126 |
52/16.4/0126 |
2022/10/08 |
Registered
|
info |
| Pharmacare Limited û Woodmead |
OROTHROAT PLUS LEMON LOZENGES |
Each lozenge contains 2,4-DICHLOROBENZYL ALCOHOL 1,2 mg and AMYLMETACRESOL 0,6 mg and LIDOCAINE HYDROCHLORIDE 10,0 mg |
520127 |
52/16.4/0127 |
2022/10/08 |
Registered
|
info |
| Pharmacare Limited û Woodmead |
OROTHROAT PLUS ORANGE LOZENGES |
Each lozenge contains: 2,4-DICHLOROBENZYL ALCOHOL 1,2 mg AMYLMETACRESOL 0,6 mg and LIDOCAINE HYDROCHLORIDE 10,0 mg |
520128 |
52/16.4/0128 |
2022/10/08 |
Registered
|
info |
| Pharma Dynamics (Pty) Ltd |
OCURINZ |
Each 1 ml contains BRINZOLAMIDE 10,0 mg |
510920 |
51/15.4/0920 |
2022/08/16 |
Registered
|
info |
| Oethmaan Biosims (Pty) Ltd |
OBIHIST 120 MG |
Each tablet contains FEXOFENADINE HYDROCHLORIDE 120,0 mg |
480448 |
48/5.7.1/0448 |
2022/08/16 |
Registered
|
info |
| Oethmaan Biosims (Pty) Ltd |
OBIHIST 180 MG |
Each tablet contains FEXOFENADINE HYDROCHLORIDE 180,0 mg |
480449 |
48/5.7.1/0449 |
2022/08/16 |
Registered
|
info |
| Austell Pharmaceuticals (Pty) Ltd |
OXYCORRELL 10 MG ONCE DAILY |
Each tablet contains OXYCODONE HYDROCHLORIDE 10,0 mg |
500941 |
50/2.9/0941 |
2022/08/16 |
Registered
|
info |
| Austell Pharmaceuticals (Pty) Ltd |
OXYCORRELL 20 MG ONCE DAILY |
Each tablet contains OXYCODONE HYDROCHLORIDE 20,0 mg |
500942 |
50/2.9/0942 |
2022/08/16 |
Registered
|
info |
| Austell Pharmaceuticals (Pty) Ltd |
OXYCORRELL 40 MG ONCE DAILY |
Each tablet contains OXYCODONE HYDROCHLORIDE 40,0 mg |
500943 |
50/2.9/0943 |
2022/08/16 |
Registered
|
info |
| Austell Pharmaceuticals (Pty) Ltd |
OXYCORRELL 80 MG ONCE DAILY |
Each tablet contains OXYCODONE HYDROCHLORIDE 80,0 mg |
500944 |
50/2.9/0944 |
2022/08/16 |
Registered
|
info |
| Pharma Dynamics (Pty) Ltd |
OCUTRA |
Each 1,0 ml sterile solution contains TRAVOPROST 40,0 ?g |
519002 |
51/15.4/9002 |
2022/08/16 |
Registered
|
info |
| Unicorn Pharmaceuticals (Pty) Ltd |
OLOPATADINE CLICKS |
Each 1 ml of solution contains OLOPATADINE HYDROCHLORIDE EQUIVALENT TO OLOPATADINE 1,0 mg |
520893 |
52/15.4/0893 |
2022/08/23 |
Registered
|
info |
| Activo Health (Pty) Ltd |
OCULATA |
Each 1 ml of solution contains LATANOPROST 50,0 mcg |
491145 |
49/15.4/1145 |
2022/08/23 |
Registered
|
info |
| Pharma Dynamics (Pty) Ltd |
OCUDOR 2 % |
Each 1 ml of solution contains DORZOLAMIDE HYDROCHLORIDE EQUIVALENT TO DORZOLAMIDE 20,0 mg |
510100 |
51/15.4/0100 |
2022/08/30 |
Registered
|
info |
| Activo Health (Pty) Ltd |
OLOTIVO |
Each 1,0 ml contains 1,11 mg OLOPATADINE HYDROCHLORIDE EQUIVALENT TO OLOPATADINE 1,0 mg |
491209 |
49/15.4/1209 |
2022/05/09 |
Registered
|
info |
| Activo Health (Pty) Ltd |
OCULATIM |
Each 1,0 ml contains LATANOPROST 0,05 mg and TIMOLOL MALEATE EQUIVALENT TO TIMOLOL 5,0 mg |
500403 |
50/15.4/0403 |
2022/05/09 |
Registered
|
info |
| Sandoz South Africa (Pty) Ltd |
Oreoxal 100 |
EACH TABLET CONTAINS
CEFPODOXIME PROXETIL EQUIVALENT TO CEFPODOXIME 100,0 mg |
A400735 |
A40/20.1.1/0735 |
2014/07/31 |
#N/A
|
info |
